<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Overview of nerve conduction studies</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Overview of nerve conduction studies</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Overview of nerve conduction studies</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Robert Henderson, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Clifton L Gooch, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jeremy M Shefner, MD, PhD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Richard P Goddeau, Jr, DO, FAHA</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Nov 07, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>The unique electrical properties of peripheral nerves can be evaluated in health and disease with externally applied stimuli and analysis of the consequent neurophysiologic responses. Nerve conduction study (NCS) techniques permit stimulation and recording of electrical activity from individual peripheral nerves with sufficient accuracy, reproducibility, and standardization to determine normal values, characterize abnormal findings, and correlate neurophysiologic-pathologic features.</p><p>These clinical studies are used to:</p><p class="bulletIndent1"><span class="glyph">●</span>Diagnose focal and generalized disorders of peripheral nerves</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Aid in the differentiation of primary nerve and muscle disorders (although NCS itself evaluates nerve and not muscle)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Classify peripheral nerve conduction abnormalities due to axonal degeneration, demyelination, and conduction block</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Prognosticate regarding clinical course and efficacy of treatment</p><p></p><p>The basic anatomy, physiology, and pathophysiology of the peripheral nervous system, as reflected in the clinical study of nerve conduction, will be reviewed here. Needle electromyography is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/5145.html" rel="external">"Overview of electromyography"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">ANATOMY AND NORMAL NEUROPHYSIOLOGY</span><span class="headingEndMark"> — </span>Most peripheral nerves are composed of nerve fibers with motor, sensory, and autonomic functions; these are "mixed" nerves. However, certain nerves available for clinical neurophysiologic investigation contain primarily motor fibers (eg, anterior interosseous branch of the median nerve, posterior interosseous branch of the radial nerve) or primarily sensory fibers (eg, sural, superficial peroneal, superficial radial nerves).</p><p>The most widely used classification of individual nerve fibers relates to their diameters, myelin properties, and conductivity [<a href="#rid1">1</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>A-alpha (or A-alpha beta) are large myelinated fibers, 6 to 15 microns in diameter. The largest muscle afferent fibers are sometimes classified as 1a fibers.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A-delta are small myelinated fibers, three to five microns in diameter.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>C fibers are unmyelinated fibers, 0.5 to 2 microns in diameter.</p><p></p><p>Functionally, most efferent motor fibers are large myelinated (A-alpha). Sensory fibers mediating touch, vibration, and position senses are also large myelinated (A-alpha), while those that mediate cold temperature and pain sensations are small myelinated (A-delta), and those that mediate warm, itch, and pain sensations are unmyelinated C fibers. Efferent postganglionic sympathetic autonomic fibers are unmyelinated C fibers.</p><p>Clinical neurophysiologic techniques are able to study only the largest A-alpha fibers; this poses a problem in clinical situations where strength and vibration and position senses are unaffected, but pain and temperature sensations are abnormal, a condition frequently referred to as "small-fiber neuropathy." NCS are normal in pure small-fiber neuropathies. (See  <a class="medical medical_review" href="/z/d/html/14144.html" rel="external">"Skin biopsy for the evaluation of peripheral nerve disease", section on 'Small fiber neuropathy'</a>.)</p><p class="headingAnchor" id="H3"><span class="h2">Compound action potentials</span><span class="headingEndMark"> — </span>Sensory nerve action potentials (SNAPs) and compound muscle action potentials (CMAPs) are compound potentials that represent the summated electrical activity of individual nerve fibers simultaneously activated by nerve stimulation. For both SNAPs and CMAPs (recorded from muscle), this electrical activity is generated by A-alpha fibers. With special techniques, such as digital averaging of many stimulus responses with near-nerve recording electrodes, electrical activity of sensory A-delta fibers can be visualized [<a href="#rid2">2</a>].</p><p>Conductivity in myelinated fibers is saltatory (ie, node-to-node [Ranvier] depolarization) and the speed of conduction is fiber-diameter dependent. The largest fibers conduct the fastest; the relationship between fiber diameter and conduction velocity of electrical impulses is roughly linear with a conversion factor of approximately 4.3 m/s/micron in healthy people [<a href="#rid2">2-5</a>]. Thus, 14 to 15 micron A-alpha fibers conduct in the range of 65 to 70 m/s, whereas six to seven micron A-alpha fibers conduct at approximately 30 to 35 m/s.</p><p>For the SNAP, the peak-to-peak amplitude and the area under the waveform of the compound potential reflects the number of nerve fibers activated, while the CMAP amplitude more accurately reflects the number of activated muscle fibers than nerve fibers.</p><p>In acute nerve lesions, when nerve regeneration has not had time to develop, the loss of motor nerve fibers parallels the loss of muscle fibers capable of being activated, and CMAP amplitude is reduced accordingly. In chronic nerve lesions, however, CMAP amplitude is a poor estimate of motor nerve fiber number because surviving motor units reinnervate previously denervated muscle fibers via collateral sprouting of terminal motor nerve fiber branches [<a href="#rid6">6</a>]. Subsequent to this process of reinnervation, the number of muscle fibers innervated by the surviving motor nerve fibers is larger, and stimulation can result in a CMAP where the amplitude is normal or only mildly reduced. In this context, contributions from electromyography and motor unit number estimation techniques may be helpful. (See  <a class="medical medical_review" href="/z/d/html/5145.html" rel="external">"Overview of electromyography"</a> and <a class="local">'Motor unit number estimates (MUNE)'</a> below.)</p><p class="headingAnchor" id="H4"><span class="h2">Temporal dispersion</span><span class="headingEndMark"> — </span>Differences in conduction speed of A-alpha myelinated fibers contributing to compound evoked potentials create a temporal dispersion of electrical activities such that the largest and fastest conducting fibers contribute to the earliest part of the potential and slower conducting fibers contribute to later parts. Thus, the onset latency of a compound evoked potential is determined by the conduction speed of the fastest fibers. In addition, the evoked potential has a measurable duration from the time it first leaves the baseline to when it returns.</p><p>The concept of temporal dispersion can be understood by envisioning an automobile race over a distance of 120 miles; the fastest cars travel 60 miles per hour and the slowest 40 miles per hour. Shortly after the start, the cars are bunched together, and their concentration (representing CMAP amplitude) is greatest, while the spread between the fastest and slowest cars (representing duration) is shortest. However, as the race proceeds, cars splay out and their concentration at any one point decreases. When the fastest cars reach the finish line at two hours, the slowest cars are 40 miles behind. There, the concentration (amplitude) of cars is less than anywhere previously and the distance (duration) between the fastest and slowest cars is greatest.</p><p>With increasing lengths of nerve segment between stimulating and recording electrodes, temporal dispersion increases and amplitude decreases (<a class="graphic graphic_figure graphicRef78960" href="/z/d/graphic/78960.html" rel="external">figure 1</a>). As an example, one study of upper extremity nerves recorded from hand muscles found that proximal stimulation at Erb's point in the supraclavicular fossa resulted in a 20 percent decline in CMAP amplitude and a 10 percent increase in CMAP negative phase duration compared with distal stimulation at the wrist [<a href="#rid7">7</a>].</p><p>Abnormal temporal dispersion is characterized by an excessive difference in slowing between individual motor axons within a nerve; it typically results from altered or damaged myelin [<a href="#rid8">8</a>]. The consensus criteria from the American Academy of Neurology, created for research purposes, define abnormal temporal dispersion as &gt;20 percent drop in CMAP amplitude and &gt;15 percent change in CMAP duration between proximal and distal sites [<a href="#rid9">9</a>]. The American Association of Neuromuscular and Electrodiagnostic Medicine criteria define it as &gt;30 percent increase in proximal versus distal CMAP duration [<a href="#rid10">10</a>]. The relationship between increasing temporal dispersion and increasing length of nerve segment is approximately linear for motor conduction [<a href="#rid11">11</a>] but not so for sensory conduction. (See <a class="local">'Sensory nerve conduction'</a> below.)</p><p class="headingAnchor" id="H5"><span class="h2">Phase cancellation</span><span class="headingEndMark"> — </span>Because the recorded potentials of both single motor units and single sensory fibers have both positive and negative components, phase cancellation can occur depending on the conduction velocity of individual fibers. Phase cancellation becomes more significant with greater distances between stimulating and recording electrodes.</p><p>Individual sensory and motor nerve fibers contribute differently to compound SNAPs and CMAPs, respectively. A single large myelinated sensory fiber action potential has a much shorter duration (typically 2 msec) than a single motor unit potential (typically 5 to 15 msec). Because of this short duration, a small amount of dispersion will produce a much more dramatic reduction in SNAP amplitude than CMAP amplitude. Increasing conduction distance decreases median and ulnar SNAP amplitudes 16 to 17 times more than corresponding decreases in CMAP amplitudes [<a href="#rid7">7</a>]. However, there are no accepted criteria for the extent to which SNAP amplitude may decline with increasing distance between stimulating and recording electrodes. This issue becomes important when considering diagnostic criteria for demyelinating diseases of nerve.</p><p class="headingAnchor" id="H6"><span class="h2">Saltatory conduction</span><span class="headingEndMark"> — </span>"Saltatory conduction" is the term used to describe the rapid propagation of action potentials along myelinated fibers in which nodes of Ranvier are interspersed between myelinated internodal areas along the axon. Conduction jumps from node to node along the nerve fiber by activation of inward sodium currents, which generate an outward capacitive (driving) current at the next node. The nodal membrane is depolarized to threshold, opening sodium channels and initiating another cycle [<a href="#rid12">12</a>]. When the driving current exceeds the threshold current of the nerve, conduction occurs. The ratio of driving current to threshold current is the safety factor and is normally &gt;5 [<a href="#rid13">13</a>]. Because of saltatory conduction, the conduction velocity of myelinated fibers is &gt;10 times faster than what would be predicted for an unmyelinated axon of the same diameter.</p><p>Original theories regarding saltatory conduction posited that the myelin sheath acted as an insulator, preventing current leakage along the internodal axon. However, later evidence suggested that myelin may actually leak current and that its major role is to limit nodal capacitance to a minimum, thereby allowing the node to depolarize rapidly to threshold. In this model, the most important section of the myelin sheath responsible for maintaining saltatory conduction is the paranodal area [<a href="#rid12">12</a>]. One report found that reduced nodal and paranodal ionic conductances in motor and sensory axons in vivo predated clinical symptoms, signs, and electrophysiologic abnormalities in patients with type 1 diabetes mellitus [<a href="#rid14">14</a>].</p><p class="headingAnchor" id="H7"><span class="h2">Physiologic factors affecting nerve conduction</span></p><p class="headingAnchor" id="H8"><span class="h3">Specific nerves and nerve segments</span><span class="headingEndMark"> — </span>Normative data for distal latencies, conduction velocities, and evoked potential measurements vary in regard to specific nerves and nerve segments. For instance, nerve conduction velocities are 15 to 20 percent faster in upper extremity nerves than in lower extremity nerves and 5 to 10 percent faster in proximal segments compared with distal segments [<a href="#rid15">15</a>]. Sensory conduction is 5 to 10 percent faster than motor conduction for each mixed nerve segment [<a href="#rid15">15</a>].</p><p class="headingAnchor" id="H9"><span class="h3">Age</span><span class="headingEndMark"> — </span>Nerve conduction velocities are approximately half normal adult values in full-term infants and increase into the adult range by age three to five years [<a href="#rid16">16,17</a>]. They then plateau until ages 25 to 30 years and decline slowly thereafter at approximately 1 to 3 percent per decade [<a href="#rid15">15</a>]. Decreases in median and ulnar sensory conduction velocities have been estimated at 0.13 to 0.21 m/s per year [<a href="#rid18">18</a>]. Effectively, this is a change of 10 m/s or less even into the ninth decade.</p><p>There is a negative correlation between age and evoked potential amplitude, probably related to loss of nerve fibers with aging [<a href="#rid19">19</a>]. The decline varies from nerve to nerve and is more pronounced for the SNAP than the CMAP (eg, the decline can be as much as 50 to 75 percent for the SNAP in the median, ulnar, sural, and superficial peroneal nerves between the second and ninth decades) [<a href="#rid15">15,20</a>].</p><p>The issue of absent evoked potentials in normal older adult subjects, when recording with surface electrodes, is unsettled. One study found that responses could not be recorded in &lt;1 percent of patients age 50 years and younger, whereas loss of responses was common in those aged 70 years and older [<a href="#rid19">19</a>]. The sural nerve SNAP was most vulnerable, being absent in 24 percent of patients in their eighth decade and 40 percent in their ninth [<a href="#rid19">19</a>]. However, in other studies, sural SNAPs were found in all subjects up to age 76 [<a href="#rid21">21</a>] and to age 88 years [<a href="#rid22">22</a>]. In addition, sural SNAPs were found in all normal subjects as old as age 90 years with near-nerve electrodes [<a href="#rid23">23</a>].</p><p class="headingAnchor" id="H10"><span class="h3">Height, body habitus, and sex</span><span class="headingEndMark"> — </span>There is a negative correlation between height and nerve conduction velocity, more so for lower extremity nerves, and the effect of height is greater than that of age [<a href="#rid19">19</a>]. Conversely, age has a much greater effect than height on evoked potential amplitude [<a href="#rid19">19</a>].</p><p>Female subjects typically have faster conduction velocities than males, possibly due to height differences [<a href="#rid24">24</a>]. The higher sural SNAP amplitudes seen in females may relate to differences in subcutaneous tissue at the ankle [<a href="#rid23">23</a>].</p><p>SNAP amplitudes declined with increasing body mass index in two studies but not in another [<a href="#rid21">21,22,25</a>]. Body mass index affects specific nerve segments; ulnar conduction velocities across the elbow directly correlated with body mass index but not ulnar forearm conduction velocities [<a href="#rid24">24</a>]. Possible explanations are that nerve length may be overestimated in the presence of adipose tissue or that added insulation may produce higher local nerve temperatures [<a href="#rid26">26</a>].</p><p>A study of healthy subjects confirmed the aforementioned effects of aging but found that correlations between NCS and height, weight, and sex varied among the nerves tested and that normative values varied among subjects from India, Malaysia, and China [<a href="#rid27">27</a>].</p><p class="headingAnchor" id="H11"><span class="h3">Temperature</span><span class="headingEndMark"> — </span>The temperature of nerve segments undergoing testing has a significant effect on nerve conductivity and evoked potential amplitude [<a href="#rid28">28</a>]. In normal subjects, within a range that excludes very high or very low temperatures, decreased local temperature results in the following changes:</p><p class="bulletIndent1"><span class="glyph">●</span>Increased evoked potential amplitudes, by 1.76 to 2.27 percent per degree Celsius [<a href="#rid29">29</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Increased distal latencies, by 2.52 percent per degree Celsius [<a href="#rid29">29</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Decreased conduction velocities, by 1.2 to 2.4 m/s per degree Celsius [<a href="#rid2">2,30</a>]</p><p></p><p>Because of the large magnitude of these changes and their potential role in confounding result interpretation, standardization of temperature during testing is essential. The arm should be maintained at 34 to 36°C and the leg at 32 to 34°C. The situation is of particular importance during cold weather and in patients with anxiety-induced sympathetic overactivity. External infrared heating elements, hot packs, and hot water baths can be effective in raising limb temperatures, but measured skin temperature may differ considerably from intramuscular or nerve temperatures [<a href="#rid29">29</a>]. Correction factors to compensate for low limb temperatures during testing are not recommended [<a href="#rid28">28</a>].</p><p class="headingAnchor" id="H12"><span class="h1">METHODOLOGY</span><span class="headingEndMark"> — </span>The essential parameters evaluated during clinical peripheral NCS are the amplitudes, areas, configurations, and durations of the sensory nerve action potentials (SNAPs) and compound muscle action potentials (CMAPs) evoked by peripheral nerve stimulation, and the sensory and motor nerve conduction velocities. All measures are dependent upon the integrity of the largest myelinated fibers.</p><p class="headingAnchor" id="H13"><span class="h2">Stimulation</span><span class="headingEndMark"> — </span>Peripheral nerve activation involves placement of a stimulating cathode (negative pole) and anode (positive pole) over the nerve and generating an electrical pulse between them. Negative charges accumulate under the cathode and depolarize the nerve. Simultaneously, the nerve is hyperpolarized under the anode. Modern stimulators generate a square or rectangular wave pulse, the duration and strength of which can be varied. The most commonly used durations are 0.1 to 0.2 msec, but pulses with durations of up to 1 msec may be necessary with more deeply located or diseased nerves and when studying the H reflex.</p><p>With increasing stimulus strength, a threshold level for nerve firing is reached, which is the minimum stimulus needed to depolarize some individual fibers in the underlying nerve and thereby generate a propagating action potential. Greater stimulus strength recruits more nerve fibers and progressively increases the compound action potential until a maximum size is reached. For motor conduction studies, a maximal stimulus strength can be reached such that all motor axons within the nerve that can be activated are activated. However, compared with motor axons, sensory fibers have a greater variability in fiber diameter and sensitivity to stimulation. Thus, a maximum response may be reached that represents activation of all large myelinated sensory fibers but that does not include smaller myelinated fibers.</p><p>A supramaximal stimulus, 10 to 20 percent above the maximal stimulus level, is employed to ensure that variations in stimulus intensity or inadvertent minor changes in the relationship between stimulator and nerve do not affect the action potential, particularly its amplitude and onset latency. In normal nerves, stimuli delivered through surface electrodes of 100 to 300 V, or 10 to 30 mA with a stimulus duration of 0.1 to 0.2 msec, are usually sufficient to provide supramaximal stimulation. Higher-intensity stimuli may be required at more proximal stimulation sites, especially in patients with a higher body mass index. In achieving supramaximal stimulation, stimulus intensity and duration are inversely related; the greater the stimulus intensity, the less the duration needed, and vice versa. That said, a stimulus duration of 0.2 msec may be preferred because it is most acceptable from a pain perspective [<a href="#rid31">31</a>].</p><p>Surface electrodes are convenient to use and do not puncture the skin but require considerable stimulus strength (and hence some degree of discomfort) as they are at a distance from the underlying nerve. Needle electrodes placed close to the nerve (ie, near-nerve electrodes) puncture the skin and have to be positioned properly but use less current and produce less pain during supramaximal stimulation. Additionally, there is less stimulus artifact and less stimulus spread along the nerve, so the specific site of nerve excitation and the calculated conduction velocity can be determined more precisely. Near-nerve electrodes are also able to record smaller SNAPs in diseases of nerves, especially with digital averaging to increase signal-to-noise ratio [<a href="#rid2">2,3,32</a>].</p><p class="headingAnchor" id="H14"><span class="h2">Recording</span><span class="headingEndMark"> — </span>Surface-recording electrodes are typically used to record the electrical activity resulting from nerve excitation. These electrodes, whether small reusable discs or disposable adhesive electrodes, are placed over a muscle, a sensory nerve, or a cutaneous nerve distribution. The parameters most often studied are the time (latency) between the stimulus artifact and the onset of the compound action potential, and the amplitude, duration, area, and configuration of the compound action potential.</p><p>In motor nerve studies, recording occurs from muscles. The active electrode is placed over the motor point (endplate) and the reference electrode over the distal muscle tendon; they record summated activity from all activated muscle fibers under the active electrode. The CMAP is recorded by the active electrode as a near-field potential. Although the reference electrode is considered electrically silent, it does record far-field or volume-conducted electrical activity from other concurrently activated muscles (eg, with ulnar nerve stimulation and activation of multiple hand muscles) or from faster conducting sensory fibers, thereby contributing to the CMAP and potentially interfering with the interpretation of CMAP amplitude and onset latency [<a href="#rid33">33,34</a>]. As an example, the reference electrode can record electrical activity from multiple small foot muscles during lower extremity motor NCS; the greater distances between the recording electrodes at the foot and the stimulating electrodes at the popliteal fossa (tibial nerve) or fibular head (fibular nerve) magnify the effects of temporal dispersion and phase cancellation, which can reduce the proximal CMAP amplitude enough to give the false impression of a partial conduction block [<a href="#rid35">35,36</a>]. (See <a class="local">'Conduction block'</a> below.)</p><p>For recording of sensory potentials, digital averaging of evoked responses to multiple stimuli is often employed. This technique increases the signal-to-noise ratio by the square root of the number of stimuli averaged. Small SNAPs having identical latencies after each stimulus can be differentiated from baseline, as baseline noise is reduced. This is important when studying lower extremity sensory nerves with smaller normal amplitudes, especially in older people and in patients with axonal peripheral nerve disorders.</p><p>For clean and accurate recordings of these evoked potentials, neurophysiology instruments require a "ground electrode," usually applied between stimulating and recording electrodes, to serve as a reference point and minimize electrical interference [<a href="#rid37">37</a>].</p><p class="headingAnchor" id="H15"><span class="h2">Orthodromic and antidromic recording</span><span class="headingEndMark"> — </span>When a nerve is electrically stimulated, it is depolarized. Evoked electrical activity in the nerve propagates both proximally and distally from the stimulus site.</p><p>Motor conduction studies are orthodromic, meaning that propagation of the evoked potential occurs from nerve to muscle in the direction of physiologic conduction. Sensory potentials can be recorded with either orthodromic (propagation of the evoked potential away from the sensory receptor) or antidromic (propagation of the evoked potential toward the sensory receptor) methods (<a class="graphic graphic_figure graphicRef78960" href="/z/d/graphic/78960.html" rel="external">figure 1</a>).</p><p>In clinical practice, sensory responses using antidromic recording techniques (with the stimulator placed proximal to the recording electrodes) are more frequently employed for sensory nerve conductions, mainly because the amplitude of the SNAP is larger with antidromic than with orthodromic recording [<a href="#rid2">2</a>].</p><p class="headingAnchor" id="H16"><span class="h2">Motor nerve conduction</span><span class="headingEndMark"> — </span>In the peripheral nervous system, efferent motor nerve fibers are part of the motor unit [<a href="#rid38">38</a>], which consists of an anterior horn cell (motor neuron), its axon (motor nerve), terminal nerve branches, synapses, and all individual muscle fibers so innervated.</p><p class="headingAnchor" id="H17"><span class="h3">CMAP latency, amplitude, area, and duration</span><span class="headingEndMark"> — </span>When the active recording electrode is properly placed over the motor point of the muscle, the CMAP is biphasic, beginning with negative (upward) activity as the potential leaves the baseline.</p><p class="bulletIndent1"><span class="glyph">●</span>CMAP latency is the time between stimulus onset and onset of negative peak.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>CMAP amplitude is the height of the negative peak from baseline or the difference between negative and positive peaks.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>CMAP area is the area under the negative peak waveform [<a href="#rid16">16</a>]. This measurement is calculated by computerized electronic integration of the CMAP negative waveform.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>CMAP duration is the time from onset of the negative peak to return to baseline of the end of the potential.</p><p></p><p>If the CMAP potential starts with a positive (downward) deflection, then either the active electrode is distant from the motor point or activity is being recorded from nearby muscles [<a href="#rid16">16</a>].</p><p>During repetitive nerve stimulation testing, the CMAP amplitude or area is measured after a train of 4 to 10 stimuli is applied. (See  <a class="medical medical_review" href="/z/d/html/14147.html" rel="external">"Electrodiagnostic evaluation of the neuromuscular junction", section on 'Repetitive nerve stimulation'</a>.)</p><p class="headingAnchor" id="H18"><span class="h3">Conduction velocity</span><span class="headingEndMark"> — </span>Conductivity of an electrical impulse is fastest along the main axon and slower in terminal nerve branches. At neuromuscular junctions (NMJs; synapses), acetylcholine quanta are released from nerve terminals; they activate acetylcholine receptors at muscle fiber endplates. There is depolarization of the muscle membrane, development of a motor action potential, and muscle fiber contraction. These NMJ activities add an approximately 1 msec delay to motor unit conductivity, with an additional delay due to electrical transmission along muscle fiber membranes.</p><p>Consequently, the pure conduction velocity of electrical current flowing along a motor nerve cannot be accurately measured between a single stimulating electrode placed along the nerve and a recording electrode over the muscle, because the conduction time from stimulus onset to onset of recorded electrical potential comprises not only nerve conduction but also NMJ transmission and muscle fiber conduction. The conduction time involving all three components (nerve conduction, NMJ transmission, and muscle fiber conduction) is called the terminal motor latency or distal motor latency. Normal terminal motor latency values vary from nerve to nerve, being longer in lower extremity nerves.</p><p class="headingAnchor" id="H19"><span class="h3">Calculation of motor conduction velocity</span><span class="headingEndMark"> — </span>To measure motor conduction velocity, a motor nerve must be stimulated at two points, one proximal and one more distal. The conduction time in the terminal segments of the motor unit are identical for the resulting CMAP recordings from both stimulation sites.</p><p>The pure motor conduction velocity can be calculated as follows (<a class="graphic graphic_figure graphicRef73171" href="/z/d/graphic/73171.html" rel="external">figure 2</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Measuring the distance (d) between the stimulation sites in millimeters</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Subtracting the conduction time between the distal stimulus site and the recording site (distal latency) from the conduction time between the proximal stimulus site and the recording site (proximal latency)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Dividing the distance (d) in millimeters by the difference in conduction times (proximal latency - distal latency) in milliseconds</p><p></p><p>Thus:</p><div class="formulaContainer"><div class="formula"><p>Motor conduction velocity = d / (proximal latency - distal latency)</p></div></div><p>The units are millimeters/millisecond (mm/msec), or meters/second (m/s).</p><p>Motor conduction velocity determinations are critically dependent upon accurate measurements of both distal and proximal latencies and of conduction distances between these stimulation sites. The standard consensus is that distances of at least 10 cm or more should be used to minimize measurement errors. However, with modern electrodiagnostic equipment, accurate conduction velocities can be determined with distances as short as 5 to 6 cm [<a href="#rid39">39</a>].</p><p>Upper limb position has long been recognized as affecting ulnar nerve motor conduction velocity calculations across the elbow [<a href="#rid40">40</a>]. The standard position for upper limb recording is for the elbow to be flexed at 90 degrees [<a href="#rid41">41</a>]. Lower limb position can also affect fibular motor nerve conduction across the knee and distal to the fibular head [<a href="#rid42">42</a>]. The optimal leg position for recording is flexion of the hip and extension of the knee.</p><p>Further evaluation of conduction in the terminal segment of the motor unit may differentiate demyelinating disorders that have uniform conduction slowing along the entire length of nerve (eg, hereditary motor and sensory neuropathy type 1A) and those with multifocal conduction changes and nonuniform conduction slowing (eg, hereditary neuropathy with pressure palsy, acquired inflammatory demyelinating polyneuropathies [<a href="#rid43">43</a>]) from those with disproportionate distal nerve conduction slowing (eg, polyneuropathy with antibodies against myelin-associated glycoproteins). The terminal latency index is a measure that combines distal latency and proximal conduction velocity to evaluate whether disproportionate distal slowing is present [<a href="#rid44">44</a>].</p><p class="headingAnchor" id="H20"><span class="h2">Sensory nerve conduction</span><span class="headingEndMark"> — </span>Afferent sensory fibers, which have their cell body in the dorsal root ganglia, do not have synapses within the peripheral nervous system. Therefore, electrical current flowing between stimulating and recording sensory electrodes in the periphery occurs solely along the nerve, and a conduction velocity can be derived by dividing conduction distance by conduction time between stimulating and recording electrodes. In routine studies, the sensory receptors are not evaluated.</p><p>Whereas the CMAP is measured in millivolts (mV), the SNAP is measured in microvolts (microV) (<a class="graphic graphic_figure graphicRef55496" href="/z/d/graphic/55496.html" rel="external">figure 3</a>).</p><p class="headingAnchor" id="H3134207076"><span class="h2">Late responses</span><span class="headingEndMark"> — </span>The late responses are most useful for studying the proximal segments, the plexus and nerve roots, of the peripheral nervous system.</p><p class="headingAnchor" id="H21"><span class="h3">F wave</span><span class="headingEndMark"> — </span>Electrical activity propagating proximally (antidromically) activates a small percentage of motor neurons (they "backfire"), which then can generate another wave known as the F wave (also called the F response). The F wave is a low-amplitude late potential generated by supramaximal nerve stimulation (<a class="graphic graphic_waveform graphicRef75038" href="/z/d/graphic/75038.html" rel="external">waveform 1</a>).</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Recording technique </strong>– F waves are recorded using surface electrodes over distal muscles in the same manner as motor nerve conduction studies. Supramaximal nerve stimulation is utilized with the stimulating cathode proximal to the anode to prevent anodal block of the antidromic potential.</p><p></p><p class="bulletIndent1">It is important to record at least 10 to 20 F waves for analysis because individual F waves arise from different subpopulations of motor neurons and vary in configuration, amplitude, and latency [<a href="#rid45">45</a>].</p><p></p><p class="bulletIndent1">If the stimulation site is moved proximally, the F wave latency will decrease by the same amount that the CMAP latency increases because the distance between that stimulation site and the motor neuron decreases while the distance to the recording electrodes increases. With more proximal stimulation sites, the F wave can be lost as it merges into the larger amplitude of the CMAP potential. Voluntary movement and repetitive nerve stimulation may activate F waves in patients with previously absent F waves secondary to immobility [<a href="#rid46">46</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical significance </strong>– F waves may be the most sensitive electrodiagnostic test for nerve injury, since the potentials must traverse all components (antidromic plus orthodromic) of the motor nerve [<a href="#rid47">47-49</a>]. F waves are useful for evaluating peripheral neuropathies with predominantly proximal involvement, such as the acute and chronic inflammatory demyelinating polyneuropathies, in which distal conduction velocities may be normal early in the disease [<a href="#rid50">50,51</a>].</p><p></p><p class="bulletIndent1">F wave slowing may be seen in demyelinating, axonal, and mixed polyneuropathies [<a href="#rid9">9,45,52</a>]. In demyelinating polyneuropathies, there is decreased persistence of F waves with absent F waves in the presence of relatively preserved M responses [<a href="#rid45">45</a>].</p><p></p><p class="bulletIndent1">The value of F waves in focal nerve lesions, such as radiculopathy, is controversial [<a href="#rid53">53</a>]. F wave conduction along longer normal nerve segments may "dilute" any conduction delay across much shorter radicular segments [<a href="#rid16">16</a>]. Since most peripheral nerves consist of axons from multiple nerve roots, with multiple innervations of the muscles undergoing recording, normal conductivity across unaffected roots may also dilute the abnormalities of the affected root.</p><p></p><p class="bulletIndent1">Repeater F waves are frequently seen in amyotrophic lateral sclerosis (ALS) and are associated with the degree of lower motor neuron loss [<a href="#rid54">54,55</a>]. F wave latencies and chronodispersion are also increased in ALS [<a href="#rid56">56</a>].</p><p></p><p class="headingAnchor" id="H22"><span class="h3">H reflex</span><span class="headingEndMark"> — </span>The H reflex is a true reflex with an afferent arc mediated by large, fast-conducting group 1a fibers and an efferent arc mediated by alpha motor neurons (<a class="graphic graphic_waveform graphicRef81004" href="/z/d/graphic/81004.html" rel="external">waveform 2</a>). It is visible only with submaximal stimulation and is most consistently seen with tibial nerve stimulation in the popliteal fossa when recording from the soleus and plantar foot muscles. The soleus H reflex decreases in amplitude with age but can be elicited in 92 percent of healthy people who are age 60 years and older [<a href="#rid57">57</a>].</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Recording technique </strong>– The amplitude of the H reflex is greatest just below the threshold for the appearance of the compound muscle action potential (CMAP). The H reflex disappears with maximal and supramaximal stimulation, replaced by the F wave, which has a slightly longer latency. The typical soleus H reflex latency is approximately 30 msec.</p><p></p><p class="bulletIndent1">Stimulus durations of 0.5 to 1 msec are necessary for group 1a afferent fiber activation. As with the F wave, the stimulating cathode is proximal to the anode. Optimal cathode placement for eliciting the tibial H reflex occurs at the midpoint of the popliteal fossa crease [<a href="#rid58">58</a>]. The tibial H reflex amplitude is greatest with the recording electrodes placed over the central soleus region [<a href="#rid59">59</a>]. The median nerve H reflex is best recorded with the patient sitting with forearm pronation [<a href="#rid60">60</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical significance </strong>– The H reflex is most commonly used to assess the S1 nerve root in suspected radiculopathies and to assess proximal conduction in polyneuropathies [<a href="#rid61">61,62</a>]. The H reflex improves the diagnostic sensitivity of standard neurophysiological tests in polyneuropathies [<a href="#rid63">63</a>]. Unilateral absence of the H reflex or side-to-side differences of &gt;1.5 to 2 msec support a focal nerve lesion on the affected side, most commonly at the S1 root, but also at the sacral plexus or sciatic nerve. Less frequently, the H reflex is also used to study central nervous system functions [<a href="#rid64">64</a>]. Examples include the evaluation of spinal cord injury, multiple sclerosis, and intraoperative monitoring during thoracic spine and brainstem surgeries [<a href="#rid65">65,66</a>].</p><p></p><p class="headingAnchor" id="H1935320440"><span class="h2">Blink reflex</span><span class="headingEndMark"> — </span>The blink reflex is another true reflex [<a href="#rid67">67</a>]. The afferent sensory arm is the first division of the trigeminal nerve and the efferent motor arm mediated by the facial nerve. The blink reflex can be abnormal in both peripheral and central lesions (eg, lesions of the brainstem or trigeminal or facial nerves). Evaluating the blink reflex may be useful in patients with demyelinating neuropathies where peripheral responses are unable to be obtained [<a href="#rid67">67</a>].</p><p class="headingAnchor" id="H3052876402"><span class="h2">Normative data and reference values</span><span class="headingEndMark"> — </span>Several studies have emphasized the lack of standardization and reproducibility of NCS, especially when repeated for clinical reasons or therapeutic trials [<a href="#rid41">41,68-70</a>] or when different equipment is used. Special training may minimize intra-observer variability amongst experienced clinical neurophysiologists but does not eliminate inter-observer differences [<a href="#rid69">69</a>].</p><p>Reliance on previously published normative reference data is problematic because of their lack of modern statistical and methodologic rigor and the false assumption that these data follow a bell-shaped distribution; it has been suggested that nonparametric methodology using percentiles is more suitable in the determination of reference values [<a href="#rid41">41,70,71</a>]. Other statistical methods for determining reference values for electrodiagnostic tests are under study [<a href="#rid72">72</a>]; however, large neurophysiology laboratories are encouraged to develop their own normal values for their study population. For nerves with smaller normal amplitudes or less commonly tested nerves, side-to-side comparison can be helpful.</p><p class="headingAnchor" id="H23"><span class="h1">ABNORMAL FINDINGS</span><span class="headingEndMark"> — </span>There are three main pathologic mechanisms affecting peripheral nerve:</p><p class="bulletIndent1"><span class="glyph">●</span>Axonal degeneration</p><p class="bulletIndent1"><span class="glyph">●</span>Demyelination</p><p class="bulletIndent1"><span class="glyph">●</span>Conduction block</p><p></p><p>This pathophysiologic classification is based upon an understanding of the two predominant neural structures, the axon and its myelin sheath. Peripheral nerve disorders, both focal and generalized, can affect either of these structures alone or together.</p><p class="headingAnchor" id="H24"><span class="h2">Axonal degeneration</span><span class="headingEndMark"> — </span>The primary feature of axonal degeneration seen with NCS is reduced amplitude. The conduction velocity may also be reduced to the extent that the largest axons are affected; in this setting, the measured conduction velocity reflects the velocity of the largest remaining axons. Nevertheless, the degree of conduction slowing with axonal degeneration is less than with demyelination.</p><p>Pathologic conditions affecting peripheral nerves may produce focal or general loss of axons. The axons relevant to clinical neurophysiologic studies are A-alpha fibers with diameters of 6 to 15 microns. Loss of these largest fibers is manifested as a decrease in compound muscle action potential (CMAP) amplitude and a change in configuration (increased dispersion and increased number of phases) of the compound evoked potentials. In addition, loss of enough of these fibers causes slowing in the maximum conduction velocity and an increase in the distal latency. As an example, if all fibers &gt;10 microns in diameter are lost, then the fastest conduction velocities of the remaining fibers would be in the 40 m/s range. Normally, maximum conduction velocities are in the 65 to 75 m/s range.</p><p>Small A-delta fibers make little if any contribution to the sensory nerve action potential (SNAP) [<a href="#rid3">3</a>] or CMAP, and C fibers make none. Thus, these SNAPs and CMAPs are normal in neuropathies that exclusively or predominantly affect small fibers.</p><p>By the "80 percent rule," the conduction velocity should be &gt;80 percent of the lower limits of normal when the amplitude of the evoked potential is &gt;80 percent of the normal value [<a href="#rid16">16</a>]. A greater loss of fast conducting fibers could be responsible for greater conduction slowing. However, in lesions with pure axonal loss, the conduction slowing cannot go below 70 percent of the lower limits of normal [<a href="#rid16">16</a>], or 60 percent of the normal mean value for that particular nerve and segment [<a href="#rid73">73</a>]. This is amplitude-dependent slowing (ie, conduction velocity is reduced because a subpopulation of faster conducting axons has been lost, not because of demyelination of conducting axons).</p><p>Practically, assuming the variables of height, age, and temperature are taken into account, conduction velocities &gt;30 m/s are usually compatible with axonal loss, whereas velocities &lt;30 m/s most likely reflect demyelination.</p><p>In acute axonal peripheral nerve injuries, the distal portion of the nerve is separated from the proximal portion but remains physiologically intact for a period of time despite a complete loss of nerve function (Wallerian degeneration). Few humans with such nerve injuries have been studied electrophysiologically in the early days postinjury. In the largest human study (16 patients, 20 injured nerves), the injured nerves were evaluated within three days of injury [<a href="#rid74">74</a>]. All nerves showed CMAP amplitude decay by day 4, with 85 percent of nerves reaching their CMAP plateau by day 8. Length dependency was demonstrated by the strong correlation between length of the distal nerve segment and CMAP amplitude decay.</p><p class="headingAnchor" id="H25"><span class="h2">Demyelination</span><span class="headingEndMark"> — </span>When myelin is disrupted (demyelination), especially in paranodal areas, nodal capacitance increases and resistance decreases. It takes longer for the driving current to activate the next node to threshold, resulting in slowing in internodal conduction and a reduced conduction velocity along that segment of nerve.</p><p>This slowing in conduction velocities can occur through the several patterns that follow:</p><p class="bulletIndent1"><span class="glyph">●</span>Uniform (seen in all segments of all nerves), as in hereditary motor and sensory neuropathy type 1</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Multifocal (seen in some but not all nerves or only along certain nerve segments), as in the acute and chronic inflammatory demyelinating neuropathies</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Monofocal (one nerve at one site), as in compressive lesions of the median nerve at the carpal tunnel or the ulnar nerve at the elbow</p><p></p><p>Conduction block occurs (conduction fails at that point of the axon) if the driving current falls below the threshold current (ie, if the safety factor drops below unity) [<a href="#rid12">12,13,75</a>]. (See <a class="local">'Conduction block'</a> below.)</p><p>Unfortunately, the diagnosis of primary demyelination in an individual patient or nerve can be problematic because there is a wide range of normal values for the standard parameters of nerve conduction. In addition, slowed conduction velocities and prolonged distal latencies can also occur in axonal and focal entrapment disorders [<a href="#rid52">52,76</a>].</p><p>CMAP amplitude can be normal or reduced in demyelination and conduction block. With focal sites of demyelination and block, electrical stimulation distally will result in normal CMAP amplitudes if the motor axons remain intact. However, a definite diagnosis of primary demyelination may be impossible in the context of marked reductions in distal CMAP amplitudes. That is why the consensus criteria discussed in temporal dispersion and conduction block are, in part, dependent upon CMAP amplitude [<a href="#rid9">9,10</a>]. These criteria are usually considered sufficiently specific but insufficiently sensitive to be used in clinical practice. This raises the risk of not diagnosing and, hence, not treating patients who actually have inflammatory or autoimmune demyelinating disorders that may be responsive to immunosuppressive treatments such as intravenous immunoglobulin or plasmapheresis.</p><p>Multiple studies have attempted to refine the consensus criteria in the hopes of increasing their sensitivity and specificity. Many such studies have used the electrophysiologic findings in motor neuron disorders and axonal polyneuropathies as representative of axonal degeneration and have defined criteria for primary demyelination in contrast. As an example, the following are one set of proposed criteria for primary demyelination [<a href="#rid77">77</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Motor conduction velocities ≤70 percent of the lower limit of normal.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Prolonged motor distal latency of ≥150 percent of the upper limit of normal.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Prolonged F-wave latency of ≥120 percent of the upper limit of normal with distal CMAP negative peak amplitude of &gt;80 percent of the lower limit of normal, and F-wave latency ≥150 percent of the upper limit of normal if the distal negative peak CMAP amplitude is &lt;80 percent of the lower limit of normal.</p><p></p><p>Alternatively, in hereditary motor and sensory neuropathy type 1, a condition with pathologically proven demyelination, conduction velocities are &lt;60 percent of the normal mean for that particular segment of that particular nerve [<a href="#rid73">73</a>].</p><p>Prolongation of the distal CMAP duration, due to abnormal temporal dispersion, can be an indication of distal demyelination; in isolation, this finding is not observed in axonal neuropathic disorders or in focal nerve compression syndromes (eg, carpal tunnel syndrome) [<a href="#rid78">78-80</a>]. One group of investigators determined that distal CMAP durations (from onset of the first negative deflection to return to baseline of the last negative deflection) are abnormal and indicative of demyelination when &gt;8.5 msec in acute inflammatory demyelinating polyneuropathy and &gt;9 msec in chronic inflammatory demyelinating polyneuropathy [<a href="#rid78">78,80</a>].</p><p>Nevertheless, this phenomenon cannot be used to distinguish between acquired and hereditary demyelinating polyneuropathies, since one study found that distal CMAP prolongations of &gt;9 msec occur in a clinically significant proportion of patients with hereditary demyelinating neuropathies (eg, hereditary motor and sensory neuropathy type 1A) [<a href="#rid81">81</a>]. However, the same report found abnormal distal CMAP prolongation affecting multiple nerves occurred in 39 percent of patients with chronic inflammatory demyelinating polyneuropathy [<a href="#rid81">81</a>].</p><p>In another study, a linear correlation between CMAP and SNAP action potential amplitude and conduction velocity was present in most nerves affected by axonal or demyelinating polyneuropathy [<a href="#rid82">82</a>]. Thus, the relationship between amplitude reduction and conduction slowing did not seem useful for distinguishing the degree of demyelination versus axonal loss in an individual patient with polyneuropathy.</p><p>Near-nerve studies of distal sensory nerves may be helpful in diagnosing peripheral neuropathies and sensory inflammatory demyelinating neuropathies when routine surface electrode studies are either normal or nondiagnostic [<a href="#rid32">32,83,84</a>]. Ultrasound positioning of the near-nerve recording electrode in sural nerve studies has been found superior to surface electrodes, especially in older adults [<a href="#rid20">20</a>].</p><p>There is no gold standard set of diagnostic criteria for the electrophysiologic identification of demyelination. Such criteria are difficult to devise [<a href="#rid85">85</a>]. Multiple sets of criteria for chronic inflammatory demyelinating polyneuropathy exist, with wide variation in sensitivity and specificity [<a href="#rid77">77,86-88</a>]. (See  <a class="medical medical_review" href="/z/d/html/5264.html" rel="external">"Chronic inflammatory demyelinating polyneuropathy: Etiology, clinical features, and diagnosis", section on 'Diagnosis'</a>.)</p><p>Misdiagnosis of demyelination is not uncommon, most often due to interpretive errors when amplitude-dependent conduction velocity slowing occurs (as in length-dependent axonal neuropathies or motor neuron disease) or when amplitude-independent conduction slowing is limited to known compressible sites [<a href="#rid89">89</a>]. (See  <a class="medical medical_review" href="/z/d/html/5264.html" rel="external">"Chronic inflammatory demyelinating polyneuropathy: Etiology, clinical features, and diagnosis", section on 'Diagnostic pitfalls'</a>.)</p><p class="headingAnchor" id="H26"><span class="h2">Conduction block</span><span class="headingEndMark"> — </span>Conduction block can occur with compressive lesions and acquired demyelinating nerve lesions. The key information for identifying conduction block is the amount of drop in CMAP amplitude and/or area when stimulating from more proximal, compared with distal, sites. Criteria for conduction block are specific for individual nerves, since normative data for CMAP amplitude, area, and duration vary from nerve to nerve [<a href="#rid10">10</a>].</p><p>Even in normal nerves, the effects of phase cancellation and temporal dispersion can lead to reduction in the CMAP amplitude and area, and increases in conduction velocity, when stimulating from successively more proximal sites. These changes are more pronounced for SNAPs than CMAPs. The criteria for conduction block must account for these normal changes. The American Association of Neuromuscular and Electrodiagnostic Medicine consensus criteria cite normal ranges of CMAP changes between distal and proximal stimulus sites for the more commonly tested nerves as follows [<a href="#rid10">10</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>For the median and ulnar nerves, with stimulation at the elbow versus the wrist, CMAP amplitude and area are reduced by no more than 25 and 20 percent, respectively, while duration increases by no more than 25 percent.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For the fibular nerve, with stimulation at the knee versus the ankle, CMAP amplitude and area are reduced by no more than 30 and 25 percent, respectively, while duration increases by no more than 30 percent.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For the tibial nerve, with stimulation at the knee versus the ankle, CMAP amplitude and area are reduced by no more than 50 and 30 percent, respectively, while duration increases by no more than 30 percent.</p><p></p><p>With these normal findings in mind, the American Association of Neuromuscular and Electrodiagnostic Medicine consensus criteria for definite partial conduction block in multifocal motor neuropathy, assuming a minimal contribution of temporal dispersion (&lt;30 percent), were the following [<a href="#rid10">10,90</a>]: in median and ulnar nerves, conduction block requires a reduction in CMAP amplitude of &gt;50 percent over wrist to elbow segments, and, in fibular and tibial nerves, conduction block requires a reduction in CMAP of &gt;60 percent over ankle to knee segments.</p><p>The American Academy of Neurology criteria are also used for motor nerves, which require only a &gt;20 percent decline in CMAP negative peak-to-peak amplitude with &lt;15 percent change in duration [<a href="#rid9">9</a>]. A change in CMAP amplitude of ≥20 percent is often used in clinical practice. These criteria do not apply to stimulation across Erb's point and the tibial nerve.</p><p>While temporal dispersion and its attendant desynchronization and phase cancellation contribute little to the decline in CMAP amplitude and area in normal conduction, they can make a significant contribution to CMAP amplitude or area decline in segmental demyelination, giving a false impression of conduction block [<a href="#rid16">16,91</a>]. Excessive CMAP desynchronization and phase cancellation, rather than conduction block, should be considered when a prominent reduction in CMAP amplitude is accompanied by good motor unit recruitment and strength [<a href="#rid16">16</a>]. Alternatively, abnormal temporal dispersion is an intrinsic electrophysiologic feature of multifocal motor neuropathy, independent of conduction block, and, when present, should not preclude this diagnosis whether conduction block is present or not [<a href="#rid92">92</a>]. When CMAP area is considered, a drop of &gt;50 percent denotes conduction block, independent of the amount of temporal dispersion [<a href="#rid8">8</a>].</p><p>The diagnosis of conduction block is complicated when distal CMAP amplitude is reduced. Reduced distal CMAP amplitudes may be due to distal axonal loss as seen in conditions with length-dependent axonal degeneration, distal demyelination, or distal conduction block, that is, a block in conduction between the most distal stimulus site and the recording electrode placed over muscle. (Distal conduction block may be considered when muscle weakness exists without muscle atrophy or denervation activity on electromyography.) If a reduced distal CMAP amplitude is due to axonal loss, then greater desynchronization and phase cancellation can produce further reductions in CMAP amplitude with proximal stimulation and obscure possible conduction block.</p><p>In the appropriate clinical situations, with both distal and proximal CMAP amplitude reductions, critical illness neuromyopathy should be considered, especially in association with prolonged distal and proximal CMAP durations and relatively preserved motor conduction velocities (not to demyelination levels) in two or more nerves [<a href="#rid93">93</a>]. This reduction in CMAP amplitudes and prolonged CMAP durations may be secondary to muscle fiber inexcitability. (See  <a class="medical medical_review" href="/z/d/html/5144.html" rel="external">"Neuromuscular weakness related to critical illness", section on 'Electrodiagnostic testing'</a>.)</p><p>Conduction block is significantly influenced by membrane hyperpolarization when an axon conducts a rapid train of impulses either via external stimulation [<a href="#rid94">94</a>] or voluntary activity [<a href="#rid95">95</a>]. This activity-dependent, or frequency-dependent, hyperpolarization blocks conduction when the safety factor is reduced [<a href="#rid75">75</a>]. Axonal membrane hyperpolarization was found distal to the site of conduction block in multifocal motor neuropathy [<a href="#rid96">96</a>]. In multifocal motor neuropathy, the electrophysiologic features of the block may change depending on disease duration; depolarizing blocks were seen in patients with shorter disease duration (two years) and hyperpolarizing blocks in patients with more chronic disease (five or more years) [<a href="#rid97">97</a>]. Frequency-dependent conduction block has also been found in patients with carpal tunnel syndrome and significantly prolonged motor latencies. It may explain grip weakness associated with this condition [<a href="#rid98">98</a>].</p><p>Conduction block can also be caused by mechanisms other than demyelination, such as sodium channel blockade or ischemia [<a href="#rid12">12</a>]. In multifocal motor neuropathy, antibody interference with sodium movement across the nodal membrane may play a role in conduction block [<a href="#rid96">96</a>].</p><p>Sensory fibers are much less susceptible to conduction block than motor fibers for various physiologic reasons, including protection against hyperpolarization due to greater inward rectification, a more active sodium-potassium pump, greater expression of persistent sodium channels, and a higher safety factor for impulse transmission [<a href="#rid12">12,75,95</a>]. Additionally, partial sensory conduction block may be more difficult to define because of the effects of normal temporal dispersion and phase cancellation on the SNAP [<a href="#rid3">3,7</a>]. Nonetheless, partial sensory conduction block has been demonstrated [<a href="#rid3">3</a>] and can occur in multifocal acquired demyelinating sensory and motor neuropathy (MADSAM; Lewis-Sumner syndrome) [<a href="#rid99">99,100</a>].</p><p class="headingAnchor" id="H811442389"><span class="h2">Electrophysiologic-pathologic correlations</span><span class="headingEndMark"> — </span>Electrophysiologic studies attempt to characterize abnormalities according to which mechanism predominates in a particular disorder and patient. However, this division is simplistic and not absolute; complex axon/myelin interactions exist, many diseases have both axonal loss and demyelination (eg, hereditary motor and sensory neuropathy 1, severe carpal tunnel syndrome), and axonal loss can occur secondary to disorders of myelin. In some patients, the results do not allow distinction. Further, in conditions with axonal loss, NCS findings come from conduction in fibers that are still functional, and there is no contribution from the most affected degenerated fibers [<a href="#rid101">101</a>]. In demyelinating disorders, the NCS findings reflect conduction in affected nerve fibers [<a href="#rid101">101</a>].</p><p>The determination of underlying nerve pathology utilizing electrophysiologic studies is heavily dependent upon methodology. Utilizing studies from multiple nerves with both proximal and distal stimulation and including F-wave analysis is important. Motor conduction studies are better for this purpose than sensory conduction studies, but concurrent histopathologic correlation and confirmation is not possible as motor nerves are not biopsied. However, a few studies of patients with suspected peripheral neuropathy compared sural nerve sensory conduction results obtained from surface electrodes versus those obtained from on-nerve needles placed on exposed sural nerves during biopsy [<a href="#rid102">102,103</a>]. When the electrophysiologic data were correlated with histopathologic findings, the diagnostic sensitivity for demyelination or axonal degeneration with surface sensory electrode studies was low (26 percent), whereas the diagnostic sensitivity with the on-nerve technique was much higher (69 percent) and comparable to the near-nerve technique [<a href="#rid2">2</a>].</p><p class="headingAnchor" id="H27"><span class="h1">CLINICAL APPLICATION</span></p><p class="headingAnchor" id="H2699652228"><span class="h2">Indications for testing</span><span class="headingEndMark"> — </span>NCS are invaluable in defining and determining peripheral nervous system function, dysfunction, and disease [<a href="#rid104">104,105</a>]. They are used clinically in four major ways:</p><p class="bulletIndent1"><span class="glyph">●</span>Diagnose focal and generalized disorders of peripheral nerves</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Aid in the differentiation of primary nerve and muscle disorders (although NCS itself evaluates nerve and not muscle)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Classify peripheral nerve conduction abnormalities due to axonal degeneration, demyelination, and conduction block</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Prognosticate regarding clinical course and efficacy of treatment</p><p></p><p>Some conditions (eg, conduction block) can only be diagnosed with conduction studies. Conduction studies can also provide the electropathophysiologic diagnoses in other conditions, such as axonal damage versus demyelination.</p><p>NCS may also be helpful in determining therapies, such as when to do surgery in the carpal tunnel syndrome or when to use immunosuppressive therapy in polyneuropathies. They have been thought to be reliable and reproducible, thereby providing objective evidence of efficacy with therapy and in clinical trials [<a href="#rid106">106</a>]. However, single nerve measurements may not be an adequate clinical trial outcome measure due to test-to-test variability [<a href="#rid107">107</a>].</p><p>While NCS can distinguish the type of pathophysiologic abnormalities of large myelinated fibers, they mostly cannot determine specific etiologies. Since conduction studies evaluate large myelinated fiber functions, they are often normal in polyneuropathies with predominant small-fiber involvement and in neuropathic pain conditions. Nevertheless, one study found electrodiagnostic evidence that small-fiber sensory neuropathy progresses to large fiber involvement 5 to 10 years after onset of pain [<a href="#rid108">108</a>]. NCS are also of limited value for quantifying the clinical severity of muscle weakness and large fiber sensory loss; thus, some authors view them as surrogate measures of polyneuropathy [<a href="#rid69">69</a>].</p><p>Although there is evidence of both over- and under-utilization of electrodiagnostic testing in the evaluation of suspected distal symmetric polyneuropathies, one review concluded that test results change either diagnosis or treatment in over 40 percent of patients [<a href="#rid104">104</a>]. The American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM) supports use of electrodiagnostic testing in distal symmetric polyneuropathies for the following indications [<a href="#rid105">105</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Determination of primary and alternative diagnoses</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Determination of severity, duration, and prognosis of disease</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Evaluating risk of associated problems</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Determination of the effect of medications</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Evaluating the effect of toxic exposures [<a href="#rid104">104,105</a>]</p><p></p><p>The use of electrodiagnostic testing in the evaluation of polyneuropathy is reviewed separately. (See  <a class="medical medical_review" href="/z/d/html/5284.html" rel="external">"Overview of polyneuropathy", section on 'Diagnostic evaluation'</a>.)</p><p class="headingAnchor" id="H28"><span class="h2">Concurrent electromyography</span><span class="headingEndMark"> — </span>NCS should not be performed or interpreted in isolation. They are an extension of the clinical evaluation. The AANEM recommends that NCS and electromyography should be performed and interpreted at the same time in the majority of situations [<a href="#rid53">53</a>]. This is critically important in patients with suspected radiculopathy, plexopathy, myopathy, motor neuropathy, or motor neuron disease. In addition, the complementary information derived from electromyography is useful to ensure that an underlying disease process is not missed (eg, radiculopathy in a patient with suspected carpal tunnel syndrome). (See  <a class="medical medical_review" href="/z/d/html/5145.html" rel="external">"Overview of electromyography"</a>.)</p><p class="headingAnchor" id="H1589733478"><span class="h2">Concurrent ultrasound</span><span class="headingEndMark"> — </span>Concurrent use of neuromuscular ultrasound with nerve conduction studies (and electromyography) may improve diagnostic sensitivity in entrapment neuropathies (eg, median, ulnar, or peroneal nerves) and in localization of focal nerve pathology (eg, nerve enlargement and trauma). Ultrasound can identify abnormalities in vascular supply or overall cross-sectional area, confirm the anatomical course of the nerve, and reveal associated mass lesions or bony defects [<a href="#rid109">109-112</a>].</p><p class="headingAnchor" id="H29"><span class="h2">Utility of composite scores</span><span class="headingEndMark"> — </span>Composite scores made up of several NCS attributes may be better diagnostic measures of nerve impairment than the individual NCS tests [<a href="#rid113">113,114</a>]. Composite scores may also be useful for the detection of subclinical nerve impairment [<a href="#rid115">115</a>].</p><p>In series of patients with generalized peripheral neuropathies, including patients with diabetes and those with chronic inflammatory demyelinating polyneuropathy, composite scores that incorporated nerve conduction velocities, distal latencies, and F waves of individual or multiple nerves were generally more sensitive and more reproducible than individual NCS tests for the detection of neuropathy [<a href="#rid114">114</a>] and were the most sensitive indicator of early asymptomatic functional nerve worsening over time [<a href="#rid115">115</a>].</p><p>The Total Neuropathy Score incorporates clinical criteria with a lower limb motor and sensory nerve response [<a href="#rid116">116</a>] and is used in studies of chemotherapy-induced peripheral neuropathy [<a href="#rid117">117</a>].</p><p class="headingAnchor" id="H3034899622"><span class="h2">Motor unit number estimates (MUNE)</span><span class="headingEndMark"> — </span>Methods to estimate the number of motor units were first developed from standard nerve conduction studies in commonly tested nerves such as the median, ulnar, and peroneal nerves. The size of the amplitude of the total compound muscle action potential (CMAP) represents the total number of motor units and corresponding muscle fibers activated by stimulation of a particular nerve. </p><p>By gradually increasing the stimulation intensity, the CMAP amplitude increases as additional motor units are recruited. Because of the phenomenon of phase cancellation, the increments cannot be simply counted and because the true number of motor units in a nerve is difficult to determine (eg, it is not possible to biopsy motor nerves), and a number of methods have been studied to reflect the number of motor units [<a href="#rid118">118-120</a>]. Normal values for the number of motor units in different nerve muscle-combinations have been determined for a number of different MUNE methods and, with most methods, a longitudinal decline in the number of motor units can be shown in diseases such as amyotrophic lateral sclerosis (ALS) [<a href="#rid118">118,119</a>].</p><p>In diseases such as ALS and other motor neuropathies and with normal aging, loss of motor units occurs with a compensatory process of collateral reinnervation occurring, which means the CMAP size does not fall linearly with loss of motor units. Knowledge of the number of remaining motor units represents a means of determining the pathology of motor unit loss, and MUNE is an active area of research with the potential to be used in clinical trials as a direct biomarker of motor unit loss.</p><p>There are several methods for determining the number of motor units using standard nerve conduction techniques. These include:</p><p class="bulletIndent1"><span class="glyph">●</span>Motor unit number index (MUNIX) [<a href="#rid121">121-123</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Multipoint incremental method [<a href="#rid124">124</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>MScan-Fit and other techniques measuring the CMAP scan as the stimulus intensity is gradually increased [<a href="#rid125">125</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>The neurophysiological index [<a href="#rid126">126</a>]</p><p></p><p>At present, no method has achieved widespread use nor has a method been incorporated in any of the multicenter international ALS trials.</p><p class="headingAnchor" id="H30"><span class="h2">Complications</span><span class="headingEndMark"> — </span>NCS employing surface electrodes are noninvasive. The major risks involve possible electrical injury from stray leakage currents. Intensive care unit settings predispose to increased risk when patients are attached to multiple electrical devices plugged into different power outlets. In addition, the normal protective barrier of intact, dry skin may be breached by intravenous lines, external wires, and fluid spills [<a href="#rid127">127</a>].</p><p>NCS can be safely performed in patients with implanted cardiac pacemakers and cardioverter-defibrillators [<a href="#rid128">128,129</a>]. There is the theoretical possibility that nerve stimuli can be mistaken as arrhythmias and trigger or inhibit demand pacemakers and cardioverter-defibrillators or induce atrial or ventricular fibrillation. However, in a study of NCS at routine sites, including the left supraclavicular fossa, electrical impulses were not detected by the bipolar sensing systems of these cardiac devices [<a href="#rid128">128</a>].</p><p>Pain during the procedure can be problematic [<a href="#rid129">129</a>]. One study found that providing patients with written information about the procedure beforehand reduced pain and anxiety during NCS [<a href="#rid130">130</a>]. Using a stimulus duration of ≤0.2 msec and a stimulus rate of ≤1 Hz can reduce discomfort (these parameters exclude the typical repetitive stimulation done during neuromuscular junction testing).</p><p class="headingAnchor" id="H90005394"><span class="h2">Measures to avoid electrical injury</span><span class="headingEndMark"> — </span>Safety procedures are necessary to minimize electrical leaks and injury with electrodiagnostic studies [<a href="#rid127">127,131</a>]. Most important are measures to insure proper grounding.</p><p>Additional measures for patients with cardiac pacemakers and implanted cardioverters-defibrillators include the following [<a href="#rid129">129,131</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Do not perform electrodiagnostic studies on patients with external (transcutaneous) pacer wires and consider consulting with a cardiologist before performing studies on patients with an implantable automatic cardioverter-defibrillator.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Do not stimulate within 6 inches (15 cm) of pacemakers or implantable cardioverter-defibrillators (eg, avoid ipsilateral proximal stimulation sites such as the axilla, Erb's point, and nerve roots).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Ensure all ground electrodes are functional and limit all electrodes, including the ground, to the limb of interest.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Extension cords should not be used, and patients should be disconnected from nonessential electrical equipment prior to electrodiagnostic studies.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Medical emergency carts should be available.</p><p></p><p class="headingAnchor" id="H31"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Neurophysiology</strong> – The sensory nerve action potential (SNAP) and compound muscle action potential (CMAP) are compound potentials that represent the summated electrical activity of individual nerve fibers simultaneously activated by nerve stimulation. Normal nerve conduction parameters also vary with regard to specific nerves, nerve segments, individual patient characteristics, and temperature. (See <a class="local">'Anatomy and normal neurophysiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Testing parameters</strong> – Surface-recording electrodes are typically used to record the electrical activity resulting from nerve excitation. These electrodes are placed over a muscle, a sensory nerve, or a cutaneous nerve distribution. (See <a class="local">'Methodology'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Motor nerve conduction</strong> – Stimulation of motor fibers includes the anterior horn cell (motor neuron), its axon (motor nerve), terminal nerve branches, synapses, and all individual muscle fibers innervated by a motor unit. Motor nerve testing includes assessment of conduction velocity as well as CMAP latency, amplitude, area, and duration. (See <a class="local">'Motor nerve conduction'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Sensory nerve conduction</strong> – Sensory nerve testing includes assessment of SNAP latency, amplitude, area, and duration. Conduction velocity in sensory nerves is derived by dividing conduction distance by conduction time between stimulating and recording electrodes because afferent sensory fibers do not have synapses within the peripheral nervous system. (See <a class="local">'Sensory nerve conduction'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Late responses</strong> – The F wave and H reflex are late responses that are useful for studying the proximal segments, the plexus and nerve roots, of the peripheral nervous system. F waves are useful for evaluating peripheral neuropathies with predominantly proximal involvement in which distal conduction velocities may be normal early in the disease. The H reflex is useful for evaluating the S1 nerve root in suspected radiculopathies and proximal conduction in polyneuropathies. (See <a class="local">'F wave'</a> above and <a class="local">'H reflex'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Concurrent electromyography</strong> – NCS and electromyography should be performed and interpreted at the same time in the majority of test situations. This is particularly important in patients with suspected radiculopathy, plexopathy, myopathy, motor neuropathy, or motor neuron disease. (See <a class="local">'Concurrent electromyography'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Abnormal findings</strong> – The three main pathologic mechanisms that affect peripheral nerve are axonal degeneration, demyelination, and conduction block (see <a class="local">'Abnormal findings'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The primary feature of axonal degeneration is reduced amplitude of SNAPs or CMAPs.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The primary feature of demyelination is reduced conduction velocity.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Conduction block can occur with acquired demyelinating nerve lesions. The key information is the amount of drop in CMAP amplitude and/or area when stimulating from more proximal compared with distal sites.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical applications</strong> – Nerve conduction studies (NCS) are invaluable in defining and determining peripheral nervous system function, dysfunction, and disease, both focally, as in entrapment neuropathies, and, generally, as in polyneuropathies. In addition, they are often useful in the assessment of the degree of axonal damage versus demyelination. Because they evaluate large myelinated fiber functions, conduction studies are often normal in polyneuropathies with predominant small-fiber involvement. (See <a class="local">'Clinical application'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Complications</strong> – The major risk of NCS is electrical injury from stray leakage currents. Safety procedures are necessary to minimize electrical leaks and injury. (See <a class="local">'Complications'</a> above.)</p><p></p><p class="headingAnchor" id="H881908571"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The editorial staff at UpToDate acknowledges Steven H Horowitz, MD, who contributed to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li class="breakAll">Erlanger J, Gasser HS. Electrical signs of nervous activity, University of Pennsylvania Press, Philadelphia 1937.</li><li><a class="nounderline abstract_t">Buchthal F, Rosenfalck A. Evoked action potentials and conduction velocity in human sensory nerves. Brain Res 1966; 3:1.</a></li><li><a class="nounderline abstract_t">Krarup C. Compound sensory action potential in normal and pathological human nerves. Muscle Nerve 2004; 29:465.</a></li><li><a class="nounderline abstract_t">Hursh JB. Conduction velocity and diameter of nerve fibers. Am J Physiol 1939; 127:131.</a></li><li><a class="nounderline abstract_t">Behse F, Buchthal . Sensory action potentials and biopsy of the sural nerve in neuropathy. Brain 1978; 101:473.</a></li><li><a class="nounderline abstract_t">WOHLFART G. Collateral regeneration in partially denervated muscles. Neurology 1958; 8:175.</a></li><li><a class="nounderline abstract_t">Krarup C, Trojaborg W. Sensory pathophysiology in chronic acquired demyelinating neuropathy. Brain 1996; 119 ( Pt 1):257.</a></li><li><a class="nounderline abstract_t">Bromberg MB, Franssen H. Practical rules for electrodiagnosis in suspected multifocal motor neuropathy. J Clin Neuromuscul Dis 2015; 16:141.</a></li><li><a class="nounderline abstract_t">Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Neurology 1991; 41:617.</a></li><li><a class="nounderline abstract_t">American Association of Electrodiagnostic Medicine, Olney RK. Guidelines in electrodiagnostic medicine. Consensus criteria for the diagnosis of partial conduction block. Muscle Nerve Suppl 1999; 8:S225.</a></li><li><a class="nounderline abstract_t">Schulte-Mattler WJ, Müller T, Georgiadis D, et al. Length dependence of variables associated with temporal dispersion in human motor nerves. Muscle Nerve 2001; 24:527.</a></li><li><a class="nounderline abstract_t">Kaji R. Physiology of conduction block in multifocal motor neuropathy and other demyelinating neuropathies. Muscle Nerve 2003; 27:285.</a></li><li class="breakAll">Tasaki R. Nervous transmission, Charles C Thomas, Springfield, IL 1953.</li><li><a class="nounderline abstract_t">Kwai NC, Arnold R, Poynten AM, et al. In vivo evidence of reduced nodal and paranodal conductances in type 1 diabetes. Clin Neurophysiol 2016; 127:1700.</a></li><li class="breakAll">Rosenfalck P, Rosenfalck A. Electromyography-sensory and motor conduction. Findings in normal subjects, Lab of Clin Neurophysiology, University of Copenhagen, Copenhagen, DK 1975.</li><li class="breakAll">Kimura J. Electrodiagnosis in Diseases of Nerve and Muscle, 4th ed, Oxford University Press, Oxford 2013.</li><li><a class="nounderline abstract_t">Lori S, Bertini G, Bastianelli M, et al. Peripheral nervous system maturation in preterm infants: longitudinal motor and sensory nerve conduction studies. Childs Nerv Syst 2018; 34:1145.</a></li><li><a class="nounderline abstract_t">Tong HC, Werner RA, Franzblau A. Effect of aging on sensory nerve conduction study parameters. Muscle Nerve 2004; 29:716.</a></li><li><a class="nounderline abstract_t">Rivner MH, Swift TR, Malik K. Influence of age and height on nerve conduction. Muscle Nerve 2001; 24:1134.</a></li><li><a class="nounderline abstract_t">Scheidegger O, Kihm C, Kamm CP, Rösler KM. Sural nerve conduction studies using ultrasound-guided needle positioning: Influence of age and recording location. Muscle Nerve 2016; 54:879.</a></li><li><a class="nounderline abstract_t">Overbeek BU, van Alfen N, Bor JA, Zwarts MJ. Sural/radial nerve amplitude ratio: reference values in healthy subjects. Muscle Nerve 2005; 32:613.</a></li><li><a class="nounderline abstract_t">Esper GJ, Nardin RA, Benatar M, et al. Sural and radial sensory responses in healthy adults: diagnostic implications for polyneuropathy. Muscle Nerve 2005; 31:628.</a></li><li><a class="nounderline abstract_t">Horowitz SH, Krarup C. Conduction studies of the normal sural nerve. Muscle Nerve 1992; 15:374.</a></li><li><a class="nounderline abstract_t">Robinson LR, Rubner DE, Wahl PW, et al. Influences of height and gender on normal nerve conduction studies. Arch Phys Med Rehabil 1993; 74:1134.</a></li><li><a class="nounderline abstract_t">Buschbacher RM. Body mass index effect on common nerve conduction study measurements. Muscle Nerve 1998; 21:1398.</a></li><li><a class="nounderline abstract_t">Landau ME, Barner KC, Campbell WW. Effect of body mass index on ulnar nerve conduction velocity, ulnar neuropathy at the elbow, and carpal tunnel syndrome. Muscle Nerve 2005; 32:360.</a></li><li><a class="nounderline abstract_t">Fong SY, Goh KJ, Shahrizaila N, et al. Effects of demographic and physical factors on nerve conduction study values of healthy subjects in a multi-ethnic Asian population. Muscle Nerve 2016; 54:244.</a></li><li><a class="nounderline abstract_t">Rutkove SB. Effects of temperature on neuromuscular electrophysiology. Muscle Nerve 2001; 24:867.</a></li><li><a class="nounderline abstract_t">Hopf HC, Maurer K. Temperature dependence of the electrical and mechanical responses of the adductor pollicis muscle in humans. Muscle Nerve 1990; 13:259.</a></li><li><a class="nounderline abstract_t">Dioszeghy P, Stålberg E. Changes in motor and sensory nerve conduction parameters with temperature in normal and diseased nerve. Electroencephalogr Clin Neurophysiol 1992; 85:229.</a></li><li><a class="nounderline abstract_t">Tamura A, Sonoo M, Hoshino S, et al. Stimulus duration and pain in nerve conduction studies. Muscle Nerve 2013; 47:12.</a></li><li><a class="nounderline abstract_t">Kural MA, Pugdahl K, Fuglsang-Frederiksen A, et al. Near-Nerve Needle Technique Versus Surface Electrode Recordings in Electrodiagnosis of Diabetic Polyneuropathy. J Clin Neurophysiol 2016; 33:346.</a></li><li><a class="nounderline abstract_t">Nandedkar SD, Barkhaus PE. Contribution of reference electrode to the compound muscle action potential. Muscle Nerve 2007; 36:87.</a></li><li><a class="nounderline abstract_t">Phongsamart G, Wertsch JJ, Ferdjallah M, et al. Effect of reference electrode position on the compound muscle action potential (CMAP) onset latency. Muscle Nerve 2002; 25:816.</a></li><li><a class="nounderline abstract_t">Kamel JT, Knight-Sadler RJ, Roberts LJ. Fibular motor nerve conduction studies: Investigating the mechanism for compound muscle action potential amplitude drop with proximal stimulation. Muscle Nerve 2015; 52:993.</a></li><li><a class="nounderline abstract_t">Barkhaus PE, Kincaid JC, Nandedkar SD. Tibial motor nerve conduction studies: an investigation into the mechanism for amplitude drop of the proximal evoked response. Muscle Nerve 2011; 44:776.</a></li><li><a class="nounderline abstract_t">Robinson LR, Christie M, Nandedkar S. A message from the ground electrode. Muscle Nerve 2016; 54:1010.</a></li><li><a class="nounderline abstract_t">Liddell EG, Sherrington CS. Recruitment and some other factors of reflex inhibition. Proc R Soc Lond (Biol) 1925; 97:488.</a></li><li><a class="nounderline abstract_t">Landau ME, Diaz MI, Barner KC, Campbell WW. Optimal distance for segmental nerve conduction studies revisited. Muscle Nerve 2003; 27:367.</a></li><li><a class="nounderline abstract_t">Simon NG, Walker S. The role of limb position in the interpretation of nerve conduction studies. Muscle Nerve 2017; 56:353.</a></li><li><a class="nounderline abstract_t">Chen S, Andary M, Buschbacher R, et al. Electrodiagnostic reference values for upper and lower limb nerve conduction studies in adult populations. Muscle Nerve 2016; 54:371.</a></li><li><a class="nounderline abstract_t">Broadhurst PK, Robinson LR. Effect of hip and knee position on nerve conduction in the common fibular nerve. Muscle Nerve 2017; 56:519.</a></li><li><a class="nounderline abstract_t">Lewis RA, Sumner AJ, Shy ME. Electrophysiological features of inherited demyelinating neuropathies: A reappraisal in the era of molecular diagnosis. Muscle Nerve 2000; 23:1472.</a></li><li><a class="nounderline abstract_t">Simovic D, Weinberg DH. Terminal latency index in the carpal tunnel syndrome. Muscle Nerve 1997; 20:1178.</a></li><li><a class="nounderline abstract_t">Fisher MA. F-waves--physiology and clinical uses. ScientificWorldJournal 2007; 7:144.</a></li><li><a class="nounderline abstract_t">Zimnowodzki S, Butrum M, Kimura J, et al. Emergence of F-waves after repetitive nerve stimulation. Clin Neurophysiol Pract 2020; 5:100.</a></li><li><a class="nounderline abstract_t">Fisher MA. F-waves in diabetes mellitus: Answers and questions. Muscle Nerve 2014; 49:783.</a></li><li><a class="nounderline abstract_t">Pan H, Jian F, Lin J, et al. F-wave latencies in patients with diabetes mellitus. Muscle Nerve 2014; 49:804.</a></li><li><a class="nounderline abstract_t">Jerath NU, Aul E, Reddy CG, et al. Prolongation of F-wave minimal latency: a sensitive predictor of polyneuropathy. Int J Neurosci 2016; 126:520.</a></li><li><a class="nounderline abstract_t">Kiers L, Clouston P, Zuniga G, Cros D. Quantitative studies of F responses in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. Electroencephalogr Clin Neurophysiol 1994; 93:255.</a></li><li><a class="nounderline abstract_t">Lee EB, Lee YY, Lee JM, et al. Clinical importance of F-waves as a prognostic factor in Guillain-Barré syndrome in children. Korean J Pediatr 2016; 59:271.</a></li><li><a class="nounderline abstract_t">Van den Bergh PY, Piéret F. Electrodiagnostic criteria for acute and chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 2004; 29:565.</a></li><li><a class="nounderline abstract_t">American Association of Neuromuscular &amp; Electrdiagnostic Medicine (AANEM). Proper performance and interpretation of electrodiagnostic studies. Muscle Nerve 2006; 33:436.</a></li><li><a class="nounderline abstract_t">Veltsista D, Papapavlou C, Chroni E. F Wave Analyzer, a system for repeater F-waves detection: Application in patients with amyotrophic lateral sclerosis. Clin Neurophysiol 2019; 130:1954.</a></li><li><a class="nounderline abstract_t">Oguz Akarsu E, Sirin NG, Kocasoy Orhan E, et al. Repeater F-waves in amyotrophic lateral sclerosis: Electrophysiologic indicators of upper or lower motor neuron involvement? Clin Neurophysiol 2020; 131:96.</a></li><li><a class="nounderline abstract_t">Joyce NC, Carter GT. Electrodiagnosis in persons with amyotrophic lateral sclerosis. PM R 2013; 5:S89.</a></li><li><a class="nounderline abstract_t">Falco FJ, Hennessey WJ, Goldberg G, Braddom RL. H reflex latency in the healthy elderly. Muscle Nerve 1994; 17:161.</a></li><li><a class="nounderline abstract_t">Özyurt MG, Shabsog M, Dursun M, Türker KS. Optimal location for eliciting the tibial H-reflex and motor response. Muscle Nerve 2018; 58:828.</a></li><li><a class="nounderline abstract_t">Botter A, Vieira TM. Optimization of surface electrodes location for H-reflex recordings in soleus muscle. J Electromyogr Kinesiol 2017; 34:14.</a></li><li><a class="nounderline abstract_t">Alrowayeh HN. Intra- and intersession reliabilities of the flexor carpi radialis H-reflex while sitting with forearm pronation. Int J Neurosci 2020; 130:213.</a></li><li><a class="nounderline abstract_t">Cho SC, Ferrante MA, Levin KH, et al. Utility of electrodiagnostic testing in evaluating patients with lumbosacral radiculopathy: An evidence-based review. Muscle Nerve 2010; 42:276.</a></li><li><a class="nounderline abstract_t">Berciano J, Sedano MJ, Pelayo-Negro AL, et al. Proximal nerve lesions in early Guillain-Barré syndrome: implications for pathogenesis and disease classification. J Neurol 2017; 264:221.</a></li><li><a class="nounderline abstract_t">Teigland OH, Pugdahl K, Fuglsang-Frederiksen A, Tankisi H. Utility of the H-reflex in diagnosing polyneuropathy. Muscle Nerve 2019; 60:424.</a></li><li><a class="nounderline abstract_t">Misiaszek JE. The H-reflex as a tool in neurophysiology: its limitations and uses in understanding nervous system function. Muscle Nerve 2003; 28:144.</a></li><li><a class="nounderline abstract_t">Kumru H, Albu S, Valls-Sole J, et al. Influence of spinal cord lesion level and severity on H-reflex excitability and recovery curve. Muscle Nerve 2015; 52:616.</a></li><li><a class="nounderline abstract_t">Feyissa AM, Tummala S. Intraoperative neurophysiologic monitoring with Hoffmann reflex during thoracic spine surgery. J Clin Neurosci 2015; 22:990.</a></li><li><a class="nounderline abstract_t">Wang W, Litchy WJ, Mandrekar J, et al. Blink reflex role in algorithmic genetic testing of inherited polyneuropathies. Muscle Nerve 2017; 55:316.</a></li><li><a class="nounderline abstract_t">Dyck PJ, Albers JW, Wolfe J, et al. A trial of proficiency of nerve conduction: greater standardization still needed. Muscle Nerve 2013; 48:369.</a></li><li><a class="nounderline abstract_t">Litchy WJ, Albers JW, Wolfe J, et al. Proficiency of nerve conduction using standard methods and reference values (Cl. NPhys Trial 4). Muscle Nerve 2014; 50:900.</a></li><li><a class="nounderline abstract_t">Dillingham T, Chen S, Andary M, et al. Establishing high-quality reference values for nerve conduction studies: A report from the normative data task force of the American Association Of Neuromuscular &amp; Electrodiagnostic Medicine. Muscle Nerve 2016; 54:366.</a></li><li><a class="nounderline abstract_t">Robinson LR. It's time to move on from the bell curve. Muscle Nerve 2017; 56:859.</a></li><li><a class="nounderline abstract_t">Nandedkar SD, Sanders DB, Hobson-Webb LD, et al. The extrapolated reference values procedure: Theory, algorithm, and results in patients and control subjects. Muscle Nerve 2018; 57:90.</a></li><li><a class="nounderline abstract_t">Buchthal F, Behse F. Peroneal muscular atrophy (PMA) and related disorders. I. Clinical manifestations as related to biopsy findings, nerve conduction and electromyography. Brain 1977; 100 Pt 1:41.</a></li><li><a class="nounderline abstract_t">Eder M, Schulte-Mattler W, Pöschl P. Neurographic course Of Wallerian degeneration after human peripheral nerve injury. Muscle Nerve 2017; 56:247.</a></li><li><a class="nounderline abstract_t">Kaji R, Bostock H, Kohara N, et al. Activity-dependent conduction block in multifocal motor neuropathy. Brain 2000; 123 ( Pt 8):1602.</a></li><li><a class="nounderline abstract_t">Stino AM, Naddaf E, Dyck PJ, Dyck PJB. Chronic inflammatory demyelinating polyradiculoneuropathy-Diagnostic pitfalls and treatment approach. Muscle Nerve 2021; 63:157.</a></li><li><a class="nounderline abstract_t">Van den Bergh PYK, van Doorn PA, Hadden RDM, et al. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force-Second revision. Eur J Neurol 2021; 28:3556.</a></li><li><a class="nounderline abstract_t">Thaisetthawatkul P, Logigian EL, Herrmann DN. Dispersion of the distal compound muscle action potential as a diagnostic criterion for chronic inflammatory demyelinating polyneuropathy. Neurology 2002; 59:1526.</a></li><li><a class="nounderline abstract_t">Cleland JC, Logigian EL, Thaisetthawatkul P, Herrmann DN. Dispersion of the distal compound muscle action potential in chronic inflammatory demyelinating polyneuropathy and carpal tunnel syndrome. Muscle Nerve 2003; 28:189.</a></li><li><a class="nounderline abstract_t">Cleland JC, Malik K, Thaisetthawatkul P, et al. Acute inflammatory demyelinating polyneuropathy: contribution of a dispersed distal compound muscle action potential to electrodiagnosis. Muscle Nerve 2006; 33:771.</a></li><li><a class="nounderline abstract_t">Stanton M, Pannoni V, Lewis RA, et al. Dispersion of compound muscle action potential in hereditary neuropathies and chronic inflammatory demyelinating polyneuropathy. Muscle Nerve 2006; 34:417.</a></li><li><a class="nounderline abstract_t">Tankisi H, Pugdahl K, Johnsen B, Fuglsang-Frederiksen A. Correlations of nerve conduction measures in axonal and demyelinating polyneuropathies. Clin Neurophysiol 2007; 118:2383.</a></li><li><a class="nounderline abstract_t">Kural MA, Karlsson P, Pugdahl K, et al. Diagnostic utility of distal nerve conduction studies and sural near-nerve needle recording in polyneuropathy. Clin Neurophysiol 2017; 128:1590.</a></li><li><a class="nounderline abstract_t">Odabasi Z, Oh SJ. Diagnostic value of the near-nerve needle sensory nerve conduction in sensory inflammatory demyelinating polyneuropathy. Muscle Nerve 2018; 57:414.</a></li><li><a class="nounderline abstract_t">van Dijk JG. Too many solutions for one problem. Muscle Nerve 2006; 33:713.</a></li><li><a class="nounderline abstract_t">Breiner A, Brannagan TH 3rd. Comparison of sensitivity and specificity among 15 criteria for chronic inflammatory demyelinating polyneuropathy. Muscle Nerve 2014; 50:40.</a></li><li><a class="nounderline abstract_t">Hughes RA, Bouche P, Cornblath DR, et al. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur J Neurol 2006; 13:326.</a></li><li><a class="nounderline abstract_t">Dimachkie MM, Barohn RJ. Chronic inflammatory demyelinating polyneuropathy. Curr Treat Options Neurol 2013; 15:350.</a></li><li><a class="nounderline abstract_t">Allen JA, Ney J, Lewis RA. Electrodiagnostic errors contribute to chronic inflammatory demyelinating polyneuropathy misdiagnosis. Muscle Nerve 2018; 57:542.</a></li><li><a class="nounderline abstract_t">Olney RK, Lewis RA, Putnam TD, et al. Consensus criteria for the diagnosis of multifocal motor neuropathy. Muscle Nerve 2003; 27:117.</a></li><li><a class="nounderline abstract_t">Van Asseldonk JT, Van den Berg LH, Wieneke GH, et al. Criteria for conduction block based on computer simulation studies of nerve conduction with human data obtained in the forearm segment of the median nerve. Brain 2006; 129:2447.</a></li><li><a class="nounderline abstract_t">Ghosh A, Virgincar A, Kennett R, et al. The effect of treatment upon temporal dispersion in IvIg responsive multifocal motor neuropathy. J Neurol Neurosurg Psychiatry 2005; 76:1269.</a></li><li><a class="nounderline abstract_t">Kramer CL, Boon AJ, Harper CM, Goodman BP. Compound muscle action potential duration in critical illness neuromyopathy. Muscle Nerve 2018; 57:395.</a></li><li><a class="nounderline abstract_t">Bostock H, Grafe P. Activity-dependent excitability changes in normal and demyelinated rat spinal root axons. J Physiol 1985; 365:239.</a></li><li><a class="nounderline abstract_t">Vagg R, Mogyoros I, Kiernan MC, Burke D. Activity-dependent hyperpolarization of human motor axons produced by natural activity. J Physiol 1998; 507 ( Pt 3):919.</a></li><li><a class="nounderline abstract_t">Kiernan MC, Guglielmi JM, Kaji R, et al. Evidence for axonal membrane hyperpolarization in multifocal motor neuropathy with conduction block. Brain 2002; 125:664.</a></li><li><a class="nounderline abstract_t">Priori A, Bossi B, Ardolino G, et al. Pathophysiological heterogeneity of conduction blocks in multifocal motor neuropathy. Brain 2005; 128:1642.</a></li><li><a class="nounderline abstract_t">Watson BV, Brown WF, Doherty TJ. Frequency-dependent conduction block in carpal tunnel syndrome. Muscle Nerve 2006; 33:619.</a></li><li><a class="nounderline abstract_t">Saperstein DS, Amato AA, Wolfe GI, et al. Multifocal acquired demyelinating sensory and motor neuropathy: the Lewis-Sumner syndrome. Muscle Nerve 1999; 22:560.</a></li><li><a class="nounderline abstract_t">Saperstein DS, Katz JS, Amato AA, Barohn RJ. Clinical spectrum of chronic acquired demyelinating polyneuropathies. Muscle Nerve 2001; 24:311.</a></li><li><a class="nounderline abstract_t">Krarup C. Nerve conduction studies in selected peripheral nerve disorders. Curr Opin Neurol 2002; 15:579.</a></li><li><a class="nounderline abstract_t">Oh SJ, Hemmi S, Hatanaka Y. On-nerve needle nerve conduction study in the sural nerve: A new technique for evaluation of peripheral neuropathy. Clin Neurophysiol 2015; 126:1811.</a></li><li><a class="nounderline abstract_t">Oh SJ, Hemmi S, Hatanaka Y. Diagnostic markers of axonal degeneration and demyelination in sensory nerve conduction. Muscle Nerve 2016; 53:866.</a></li><li><a class="nounderline abstract_t">Bodofsky EB, Carter GT, England JD. Is electrodiagnosic testing for polyneuropathy overutilized? Muscle Nerve 2017; 55:301.</a></li><li><a class="nounderline abstract_t">AANEM policy statement on electrodiagnosis for distal symmetric polyneuropathy. Muscle Nerve 2018; 57:337.</a></li><li><a class="nounderline abstract_t">Bird SJ, Brown MJ, Spino C, et al. Value of repeated measures of nerve conduction and quantitative sensory testing in a diabetic neuropathy trial. Muscle Nerve 2006; 34:214.</a></li><li><a class="nounderline abstract_t">Lanza G, Kosac A, Trajkovic G, Whittaker RG. Nerve Conduction Studies as a Measure of Disease Progression: Objectivity or Illusion? J Neuromuscul Dis 2017; 4:209.</a></li><li><a class="nounderline abstract_t">Walk D, Zaretskaya M, Parry GJ. Symptom duration and clinical features in painful sensory neuropathy with and without nerve conduction abnormalities. J Neurol Sci 2003; 214:3.</a></li><li><a class="nounderline abstract_t">Gonzalez NL, Hobson-Webb LD. Neuromuscular ultrasound in clinical practice: A review. Clin Neurophysiol Pract 2019; 4:148.</a></li><li><a class="nounderline abstract_t">Cartwright MS, Walker FO. Neuromuscular ultrasound in common entrapment neuropathies. Muscle Nerve 2013; 48:696.</a></li><li><a class="nounderline abstract_t">Pelosi L, Mulroy E. Diagnostic sensitivity of electrophysiology and ultrasonography in ulnar neuropathies of different severity. Clin Neurophysiol 2019; 130:297.</a></li><li><a class="nounderline abstract_t">Kerasnoudis A, Tsivgoulis G. Nerve Ultrasound in Peripheral Neuropathies: A Review. J Neuroimaging 2015; 25:528.</a></li><li><a class="nounderline abstract_t">Robinson LR, Micklesen PJ. Expression of nerve conduction test results. Muscle Nerve 2002; 25:123.</a></li><li><a class="nounderline abstract_t">Dyck PJ, Litchy WJ, Daube JR, et al. Individual attributes versus composite scores of nerve conduction abnormality: sensitivity, reproducibility, and concordance with impairment. Muscle Nerve 2003; 27:202.</a></li><li><a class="nounderline abstract_t">Dyck PJ, O'Brien PC, Litchy WJ, et al. Monotonicity of nerve tests in diabetes: subclinical nerve dysfunction precedes diagnosis of polyneuropathy. Diabetes Care 2005; 28:2192.</a></li><li><a class="nounderline abstract_t">Cornblath DR, Chaudhry V, Carter K, et al. Total neuropathy score: validation and reliability study. Neurology 1999; 53:1660.</a></li><li><a class="nounderline abstract_t">Cavaletti G, Frigeni B, Lanzani F, et al. The Total Neuropathy Score as an assessment tool for grading the course of chemotherapy-induced peripheral neurotoxicity: comparison with the National Cancer Institute-Common Toxicity Scale. J Peripher Nerv Syst 2007; 12:210.</a></li><li><a class="nounderline abstract_t">Gooch CL, Doherty TJ, Chan KM, et al. Motor unit number estimation: a technology and literature review. Muscle Nerve 2014; 50:884.</a></li><li><a class="nounderline abstract_t">de Carvalho M, Barkhaus PE, Nandedkar SD, Swash M. Motor unit number estimation (MUNE): Where are we now? Clin Neurophysiol 2018; 129:1507.</a></li><li><a class="nounderline abstract_t">Henderson RD, McCombe PA. Assessment of Motor Units in Neuromuscular Disease. Neurotherapeutics 2017; 14:69.</a></li><li><a class="nounderline abstract_t">Nandedkar SD, Nandedkar DS, Barkhaus PE, Stalberg EV. Motor unit number index (MUNIX). IEEE Trans Biomed Eng 2004; 51:2209.</a></li><li><a class="nounderline abstract_t">Nandedkar SD, Barkhaus PE, Stålberg EV. Motor unit number index (MUNIX): principle, method, and findings in healthy subjects and in patients with motor neuron disease. Muscle Nerve 2010; 42:798.</a></li><li><a class="nounderline abstract_t">Fatehi F, Grapperon AM, Fathi D, et al. The utility of motor unit number index: A systematic review. Neurophysiol Clin 2018; 48:251.</a></li><li><a class="nounderline abstract_t">Shefner JM, Watson ML, Simionescu L, et al. Multipoint incremental motor unit number estimation as an outcome measure in ALS. Neurology 2011; 77:235.</a></li><li><a class="nounderline abstract_t">Bostock H. Estimating motor unit numbers from a CMAP scan. Muscle Nerve 2016; 53:889.</a></li><li><a class="nounderline abstract_t">Swash M, de Carvalho M. The Neurophysiological Index in ALS. Amyotroph Lateral Scler Other Motor Neuron Disord 2004; 5 Suppl 1:108.</a></li><li><a class="nounderline abstract_t">Al-Shekhlee A, Shapiro BE, Preston DC. Iatrogenic complications and risks of nerve conduction studies and needle electromyography. Muscle Nerve 2003; 27:517.</a></li><li><a class="nounderline abstract_t">Schoeck AP, Mellion ML, Gilchrist JM, Christian FV. Safety of nerve conduction studies in patients with implanted cardiac devices. Muscle Nerve 2007; 35:521.</a></li><li><a class="nounderline abstract_t">London ZN. Safety and pain in electrodiagnostic studies. Muscle Nerve 2017; 55:149.</a></li><li><a class="nounderline abstract_t">Lai YL, Van Heuven A, Borire A, et al. The provision of written information and its effect on levels of pain and anxiety during electrodiagnostic studies: A randomised controlled trial. PLoS One 2018; 13:e0196917.</a></li><li class="breakAll">Preston DC, Shapiro BE. Electrical safety and iatrogenic complications. In: Electromyography and Neuromuscular Disorders: Clinical–Electrophysiologic Correlations, 3rd ed, Elsevier, New York 2013. p.614.</li></ol></div><div id="topicVersionRevision">Topic 5142 Version 19.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="javascript:alert('بدون لینک');" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Erlanger J, Gasser HS. Electrical signs of nervous activity, University of Pennsylvania Press, Philadelphia 1937.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Evoked action potentials and conduction velocity in human sensory nerves</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15052613" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Compound sensory action potential in normal and pathological human nerves.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Conduction velocity and diameter of nerve fibers</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/213163" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Sensory action potentials and biopsy of the sural nerve in neuropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13517482" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Collateral regeneration in partially denervated muscles.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8624687" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Sensory pathophysiology in chronic acquired demyelinating neuropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25695919" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Practical rules for electrodiagnosis in suspected multifocal motor neuropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2027473" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16921636" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Guidelines in electrodiagnostic medicine. Consensus criteria for the diagnosis of partial conduction block.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11268025" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Length dependence of variables associated with temporal dispersion in human motor nerves.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12635114" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Physiology of conduction block in multifocal motor neuropathy and other demyelinating neuropathies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12635114" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Physiology of conduction block in multifocal motor neuropathy and other demyelinating neuropathies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26725257" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : In vivo evidence of reduced nodal and paranodal conductances in type 1 diabetes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26725257" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : In vivo evidence of reduced nodal and paranodal conductances in type 1 diabetes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26725257" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : In vivo evidence of reduced nodal and paranodal conductances in type 1 diabetes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29637305" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Peripheral nervous system maturation in preterm infants: longitudinal motor and sensory nerve conduction studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15116376" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Effect of aging on sensory nerve conduction study parameters.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11494265" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Influence of age and height on nerve conduction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27061276" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Sural nerve conduction studies using ultrasound-guided needle positioning: Influence of age and recording location.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16116641" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Sural/radial nerve amplitude ratio: reference values in healthy subjects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15770668" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Sural and radial sensory responses in healthy adults: diagnostic implications for polyneuropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1557087" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Conduction studies of the normal sural nerve.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8239949" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Influences of height and gender on normal nerve conduction studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9771662" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Body mass index effect on common nerve conduction study measurements.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15880630" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Effect of body mass index on ulnar nerve conduction velocity, ulnar neuropathy at the elbow, and carpal tunnel syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26790132" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Effects of demographic and physical factors on nerve conduction study values of healthy subjects in a multi-ethnic Asian population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11410914" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Effects of temperature on neuromuscular electrophysiology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2320047" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Temperature dependence of the electrical and mechanical responses of the adductor pollicis muscle in humans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1380909" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Changes in motor and sensory nerve conduction parameters with temperature in normal and diseased nerve.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23042136" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Stimulus duration and pain in nerve conduction studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26657238" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Near-Nerve Needle Technique Versus Surface Electrode Recordings in Electrodiagnosis of Diabetic Polyneuropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17455266" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Contribution of reference electrode to the compound muscle action potential.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12115969" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Effect of reference electrode position on the compound muscle action potential (CMAP) onset latency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25846267" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Fibular motor nerve conduction studies: Investigating the mechanism for compound muscle action potential amplitude drop with proximal stimulation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22006693" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Tibial motor nerve conduction studies: an investigation into the mechanism for amplitude drop of the proximal evoked response.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27672738" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : A message from the ground electrode.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Recruitment and some other factors of reflex inhibition</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12635124" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Optimal distance for segmental nerve conduction studies revisited.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28345257" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : The role of limb position in the interpretation of nerve conduction studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27238640" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Electrodiagnostic reference values for upper and lower limb nerve conduction studies in adult populations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28120337" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Effect of hip and knee position on nerve conduction in the common fibular nerve.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11003782" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Electrophysiological features of inherited demyelinating neuropathies: A reappraisal in the era of molecular diagnosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9270676" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Terminal latency index in the carpal tunnel syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17334607" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : F-waves--physiology and clinical uses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32490291" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Emergence of F-waves after repetitive nerve stimulation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24154956" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : F-waves in diabetes mellitus: Answers and questions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24259350" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : F-wave latencies in patients with diabetes mellitus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26000925" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Prolongation of F-wave minimal latency: a sensitive predictor of polyneuropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7521285" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Quantitative studies of F responses in Guillain-Barrésyndrome and chronic inflammatory demyelinating polyneuropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27462356" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Clinical importance of F-waves as a prognostic factor in Guillain-Barrésyndrome in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15052622" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Electrodiagnostic criteria for acute and chronic inflammatory demyelinating polyradiculoneuropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16395691" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Proper performance and interpretation of electrodiagnostic studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31472478" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : F Wave Analyzer, a system for repeater F-waves detection: Application in patients with amyotrophic lateral sclerosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31760213" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Repeater F-waves in amyotrophic lateral sclerosis: Electrophysiologic indicators of upper or lower motor neuron involvement?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23523708" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Electrodiagnosis in persons with amyotrophic lateral sclerosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8114784" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : H reflex latency in the healthy elderly.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30028530" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Optimal location for eliciting the tibial H-reflex and motor response.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28342367" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Optimization of surface electrodes location for H-reflex recordings in soleus muscle.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31577165" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Intra- and intersession reliabilities of the flexor carpi radialis H-reflex while sitting with forearm pronation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20658602" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Utility of electrodiagnostic testing in evaluating patients with lumbosacral radiculopathy: An evidence-based review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27314967" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Proximal nerve lesions in early Guillain-Barrésyndrome: implications for pathogenesis and disease classification.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31325167" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Utility of the H-reflex in diagnosing polyneuropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12872318" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : The H-reflex as a tool in neurophysiology: its limitations and uses in understanding nervous system function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25600844" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Influence of spinal cord lesion level and severity on H-reflex excitability and recovery curve.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25769258" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Intraoperative neurophysiologic monitoring with Hoffmann reflex during thoracic spine surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27422849" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Blink reflex role in algorithmic genetic testing of inherited polyneuropathies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23861198" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : A trial of proficiency of nerve conduction: greater standardization still needed.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24644133" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Proficiency of nerve conduction using standard methods and reference values (Cl. NPhys Trial 4).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27238858" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Establishing high-quality reference values for nerve conduction studies: A report from the normative data task force of the American Association Of Neuromuscular&amp;Electrodiagnostic Medicine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28543877" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : It's time to move on from the bell curve.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28181271" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : The extrapolated reference values procedure: Theory, algorithm, and results in patients and control subjects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/861715" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Peroneal muscular atrophy (PMA) and related disorders. I. Clinical manifestations as related to biopsy findings, nerve conduction and electromyography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27875622" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Neurographic course Of Wallerian degeneration after human peripheral nerve injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10908190" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Activity-dependent conduction block in multifocal motor neuropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32914902" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Chronic inflammatory demyelinating polyradiculoneuropathy-Diagnostic pitfalls and treatment approach.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34327760" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force-Second revision.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12451191" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Dispersion of the distal compound muscle action potential as a diagnostic criterion for chronic inflammatory demyelinating polyneuropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12872323" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Dispersion of the distal compound muscle action potential in chronic inflammatory demyelinating polyneuropathy and carpal tunnel syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16523511" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Acute inflammatory demyelinating polyneuropathy: contribution of a dispersed distal compound muscle action potential to electrodiagnosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16823858" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Dispersion of compound muscle action potential in hereditary neuropathies and chronic inflammatory demyelinating polyneuropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17900975" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Correlations of nerve conduction measures in axonal and demyelinating polyneuropathies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28710923" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Diagnostic utility of distal nerve conduction studies and sural near-nerve needle recording in polyneuropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28796344" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Diagnostic value of the near-nerve needle sensory nerve conduction in sensory inflammatory demyelinating polyneuropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16688723" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Too many solutions for one problem.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24338746" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Comparison of sensitivity and specificity among 15 criteria for chronic inflammatory demyelinating polyneuropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16643309" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23564314" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Chronic inflammatory demyelinating polyneuropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29053880" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Electrodiagnostic errors contribute to chronic inflammatory demyelinating polyneuropathy misdiagnosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12508306" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Consensus criteria for the diagnosis of multifocal motor neuropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16923956" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Criteria for conduction block based on computer simulation studies of nerve conduction with human data obtained in the forearm segment of the median nerve.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16107366" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : The effect of treatment upon temporal dispersion in IvIg responsive multifocal motor neuropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28646510" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Compound muscle action potential duration in critical illness neuromyopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4032313" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Activity-dependent excitability changes in normal and demyelinated rat spinal root axons.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9508850" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Activity-dependent hyperpolarization of human motor axons produced by natural activity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11872621" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Evidence for axonal membrane hyperpolarization in multifocal motor neuropathy with conduction block.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15888541" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Pathophysiological heterogeneity of conduction blocks in multifocal motor neuropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16470526" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Frequency-dependent conduction block in carpal tunnel syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10331353" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Multifocal acquired demyelinating sensory and motor neuropathy: the Lewis-Sumner syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11353415" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Clinical spectrum of chronic acquired demyelinating polyneuropathies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12352002" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Nerve conduction studies in selected peripheral nerve disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25727898" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : On-nerve needle nerve conduction study in the sural nerve: A new technique for evaluation of peripheral neuropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26501987" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Diagnostic markers of axonal degeneration and demyelination in sensory nerve conduction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27859377" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Is electrodiagnosic testing for polyneuropathy overutilized?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29178499" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : AANEM policy statement on electrodiagnosis for distal symmetric polyneuropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16708368" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : Value of repeated measures of nerve conduction and quantitative sensory testing in a diabetic neuropathy trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28869485" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : Nerve Conduction Studies as a Measure of Disease Progression: Objectivity or Illusion?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12972380" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : Symptom duration and clinical features in painful sensory neuropathy with and without nerve conduction abnormalities.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31886438" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : Neuromuscular ultrasound in clinical practice: A review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23681885" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : Neuromuscular ultrasound in common entrapment neuropathies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30552047" id="rid110" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>111 : Diagnostic sensitivity of electrophysiology and ultrasonography in ulnar neuropathies of different severity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25996962" id="rid111" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>112 : Nerve Ultrasound in Peripheral Neuropathies: A Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11754198" id="rid112" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>113 : Expression of nerve conduction test results.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12548528" id="rid113" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>114 : Individual attributes versus composite scores of nerve conduction abnormality: sensitivity, reproducibility, and concordance with impairment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16123489" id="rid114" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>115 : Monotonicity of nerve tests in diabetes: subclinical nerve dysfunction precedes diagnosis of polyneuropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10563609" id="rid115" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>116 : Total neuropathy score: validation and reliability study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17868248" id="rid116" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>117 : The Total Neuropathy Score as an assessment tool for grading the course of chemotherapy-induced peripheral neurotoxicity: comparison with the National Cancer Institute-Common Toxicity Scale.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25186553" id="rid117" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>118 : Motor unit number estimation: a technology and literature review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29804042" id="rid118" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>119 : Motor unit number estimation (MUNE): Where are we now?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27600517" id="rid119" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>120 : Assessment of Motor Units in Neuromuscular Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15605872" id="rid120" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>121 : Motor unit number index (MUNIX).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20976783" id="rid121" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>122 : Motor unit number index (MUNIX): principle, method, and findings in healthy subjects and in patients with motor neuron disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30287192" id="rid122" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>123 : The utility of motor unit number index: A systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21676915" id="rid123" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>124 : Multipoint incremental motor unit number estimation as an outcome measure in ALS.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26479267" id="rid124" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>125 : Estimating motor unit numbers from a CMAP scan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15512888" id="rid125" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>126 : The Neurophysiological Index in ALS.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12707972" id="rid126" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>127 : Iatrogenic complications and risks of nerve conduction studies and needle electromyography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17094099" id="rid127" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>128 : Safety of nerve conduction studies in patients with implanted cardiac devices.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27680535" id="rid128" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>129 : Safety and pain in electrodiagnostic studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29758078" id="rid129" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>130 : The provision of written information and its effect on levels of pain and anxiety during electrodiagnostic studies: A randomised controlled trial.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
